Non-follicular lymphoma, hilmo, excluding all cancers

CD2_NONFOLLICULAR_LYMPHOMA_EXALLC

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

None

-

2. Check conditions

None

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 C83
  • Hospital discharge: ICD-9 200
  • Hospital discharge: excluded ICD-9 200A
  • Cause of death: ICD-10 C83
  • Cause of death: ICD-9 200
  • Cause of death: excluded ICD-9 200A

2 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

None

-

6. Filter based on genotype QC (FinnGen only)

None

-

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
C81-C96
Name in latin
Lymphoma non-Hodgkin diffusum

Similar endpoints

List of similar endpoints to Non-follicular lymphoma, hilmo, excluding all cancers based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 3604 1498 2106
Unadjusted period prevalence (%) 0.75 0.51 0.93
Median age at first event (years) 66.07 64.47 67.20

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
3254
Matched controls
32540
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
1XC02
NOMESCO Finland
NA
102.8
323.0
357
39
ZX120
NOMESCO Finland
Intravenous
9.0
323.0
779
1101
L03AA02
ATC
filgrastim; parenteral
1092.6
323.0
993
13
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
451.7
323.0
2383
196
H02AB02
ATC
dexamethasone; systemic
56.8
323.0
592
127
A03FA01
ATC
metoclopramide; systemic, rectal
18.7
323.0
1710
1818
A04AA01
ATC
ondansetron; systemic, rectal
41.9
323.0
763
236
L03AA13
ATC
pegfilgrastim; parenteral
12068.6
323.0
895
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
323.0
365
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
28.6
323.0
462
187
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
323.0
309
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
4757.6
323.0
1036
*
WW500
NOMESCO Finland
Blood transfusion
34.7
323.0
728
268
A04AA02
ATC
granisetron; systemic, transdermal
908.2
323.0
596
8
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
38.1
323.0
595
190
JN4AD
NOMESCO Finland
Body CT examination
22.5
323.0
781
450
M04AA01
ATC
allopurinol; systemic
9.5
323.0
1520
2757
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
12.5
323.0
767
781
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
323.0
326
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
2662.3
323.0
678
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
323.0
1820
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
2120.1
323.0
397
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
323.0
488
*
XW000
NOMESCO Finland
Bone marrow biopsy
41.1
323.0
1100
399
JN4BD
NOMESCO Finland
Extensive body CT
30.1
323.0
1349
747
WF002
NOMESCO Finland
Radical radiotherapy
207.2
323.0
335
18
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
323.0
400
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
323.0
454
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
169.2
323.0
401
27
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
1984.0
323.0
873
6
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
+∞
323.0
333
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
1240.4
323.0
522
5
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
2120.2
323.0
358
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
323.0
373
*
JN6AD
NOMESCO Finland
CT of torso and neck
189.5
323.0
414
25
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
182.9
323.0
443
28
PJA10
NOMESCO Finland
Exploration of lymph nodes
105.2
319.6
348
37
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
1678.1
312.3
299
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.6
312.3
1447
4838
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
307.2
290
*
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
52.7
304.1
366
78
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.5
295.5
875
1739
H02AB06
ATC
prednisolone; systemic
4.0
294.8
2156
10742
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
294.3
278
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
313.5
284.1
285
10
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
122.3
270.3
290
26
WF003
NOMESCO Finland
Adjuvant radiotherapy
479.4
269.9
266
6
R50.9
ICD-10 Finland
Fever, unspecified
5.5
260.9
899
2117
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
248.1
235
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
336.6
246.7
247
8
N02AA05
ATC
oxycodone; systemic
5.3
241.6
851
2033
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
2286.1
234.0
224
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
2263.4
231.9
222
*
9680/3-C77.8
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
228.9
217
*
XX3DW
NOMESCO Finland
Time consuming IT work
9.1
226.5
510
652
C82.1
ICD-10 Finland
Follicular lymphoma grade II
2105.1
217.0
208
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
76.3
212.3
241
34
Z51.5
ICD-10 Finland
Palliative care
13.2
194.9
356
300
ZX112
NOMESCO Finland
Subcutaneous
34.2
192.0
253
80
WW300
NOMESCO Finland
Transfer of autologic stem cells
2069.2
191.4
184
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.5
184.8
752
2027
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
82.9
179.8
202
26
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
375.3
179.3
179
5
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
176.0
1828
10027
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
175.6
167
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
80.7
174.7
197
26
130
Kela drug reimbursment
Malignant tumour
+∞
173.5
165
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
173.5
165
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
8.8
168.2
383
488
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
+∞
165.0
157
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
208.8
154.3
159
8
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
22.3
150.4
223
107
A02BC02
ATC
pantoprazole; systemic
2.7
147.7
2359
15960
H02AB07
ATC
prednisone; oral
3.6
146.7
801
2738
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
42.3
146.7
184
46
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
143.8
137
*
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
115.4
142.4
154
14
J01MA12
ATC
levofloxacin; systemic
3.2
141.5
896
3415
J05AB11
ATC
valaciclovir; oral
3.8
141.0
688
2135
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
481.2
140.4
139
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
28.8
134.7
185
68
TPX10
NOMESCO Finland
Implantation of vascular injection port
12.8
134.6
248
209
116
Kela drug reimbursment
Prostate cancer
+∞
134.3
128
*
WZC30
NOMESCO Finland
Teaching
4.2
133.9
573
1575
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
14.0
133.1
235
180
ZX090
NOMESCO Finland
Other technic of radiotherapy
452.1
132.0
131
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.7
128.1
399
781
2008X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Other named variants
+∞
127.9
122
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
10.8
126.5
253
252
JN4CD
NOMESCO Finland
Very extensive body CT
12.4
123.2
230
199
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
+∞
116.3
111
*
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
+∞
116.3
111
*
PJA12
NOMESCO Finland
Sentinel node biopsy
151.6
110.9
117
8
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
7.2
108.3
276
411
XX9CD
NOMESCO Finland
Very extensive complementary CT
+∞
107.9
103
*
C83.89
ICD-10 Finland
Other types of diffuse non-Hodgkin's lymphoma
+∞
107.9
103
*
212
Kela drug reimbursment
Gout
8.7
107.7
242
296
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
6.4
107.0
298
502
115
Kela drug reimbursment
Breast cancer
+∞
106.8
102
*
L01CB01
ATC
etoposide; systemic
+∞
104.7
100
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
104.6
987
4696
B01AB05
ATC
enoxaparin; parenteral
2.5
103.8
1129
5794
D70.89
ICD-10 Finland
Neutropenic splenomegaly
21.1
103.1
155
77
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
518.7
102.1
101
*
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
125.2
101.6
109
9
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
+∞
101.6
97
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
1008.5
100.7
98
*
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
+∞
100.5
96
*
L01AA02
ATC
chlorambucil; oral
508.0
100.1
99
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
151.8
97.7
103
7
B01AB10
ATC
tinzaparin; parenteral
5.5
97.4
309
611
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
75.3
95.9
109
15
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
95.3
91
*
B72
ICPC
Hodgkin Lymphoma
+∞
94.2
90
*
WW409
NOMESCO Finland
Other aferesis
454.8
89.6
89
*
9673/3-C42.1
ICD-O-3
Mantle cell lymphoma of bone marrow
+∞
88.9
85
*
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
+∞
88.9
85
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
88.9
85
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
35.4
87.0
113
33
C83.33
ICD-10 Finland
Primary medical lymphoma with large B cells
+∞
85.8
82
*
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
839.2
83.9
82
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.0
83.6
363
986
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.8
83.2
387
1116
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.8
82.6
297
671
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
81.7
806
3839
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.3
81.7
453
1503
A41.9
ICD-10 Finland
Sepsis, unspecified
5.6
80.8
248
469
D64.9
ICD-10 Finland
Anaemia, unspecified
3.1
79.7
504
1833
ZX080
NOMESCO Finland
Image guided radiotherapy
396.7
78.2
78
*
TGC00
NOMESCO Finland
Bronchial lavation
6.7
77.5
206
323
9591/3-C77.0
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of head, face and neck
+∞
75.3
72
*
C83.01
ICD-10 Finland
Lymphoplasmacytic lymphoma
+∞
75.3
72
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
5.9
74.7
219
391
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.1
74.5
250
523
9680/3-C71.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of brain, NOS
+∞
74.2
71
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
74.2
71
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.3
74.2
292
721
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
255.8
73.7
75
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
84.1
73.3
82
10
2000B
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM DIFFUSUM]
+∞
73.2
70
*
ZX108
NOMESCO Finland
Inhalation
24.1
73.1
105
45
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
101.2
72.2
79
8
L02AE02
ATC
leuprorelin; implant, parenteral
27.5
71.7
99
37
A79
ICPC
Malignancy NOS
129.6
71.2
76
6
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
49.0
70.9
86
18
A07AA02
ATC
nystatin; oral
3.8
70.4
322
910
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
70.0
67
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
70.0
981
5458
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
8.2
69.6
161
205
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
69.0
66
*
YNB10
NOMESCO Finland
Collection of stem cells for transplant
+∞
67.9
65
*
C83.0
ICD-10 Finland
Small cell B-cell lymphoma
+∞
67.9
65
*
9680/3-C80.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of unknown primary site
+∞
67.9
65
*
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
+∞
66.9
64
*
9591/3-C77.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS
+∞
66.9
64
*
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
+∞
66.9
64
*
J05AB01
ATC
aciclovir; systemic
2.3
66.2
736
3670
2009X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma[LYMPHOMA MALIGNUM (NON-HODGKIN) NUD]
+∞
65.8
63
*
HA1AA
NOMESCO Finland
X-ray mammography
6.7
65.7
175
275
TAB00
NOMESCO Finland
Lumbar puncture
4.6
65.4
243
565
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
11.2
63.0
122
113
FM1FN
NOMESCO Finland
Heart function isotope examination
+∞
62.7
60
*
C83.32
ICD-10 Finland
Centroblastic diffuse non-Hodgkin's lymphoma
+∞
62.7
60
*
L02BB03
ATC
bicalutamide; oral
+∞
62.7
60
*
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
619.5
62.0
61
*
C83.34
ICD-10 Finland
Anaplastic large cell lymphoma
+∞
61.6
59
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
61.6
59
*
9680/3-C42.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of bone marrow
+∞
61.6
59
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
6.3
61.6
170
280
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.9
61.5
418
1578
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.1
61.5
874
4841
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
59.5
57
*
D69.5
ICD-10 Finland
Secondary thrombocytopenia
42.0
59.3
74
18
WW402
NOMESCO Finland
Leucoferesis
588.3
58.9
58
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.3
58.6
634
3096
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.1
58.5
347
1194
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
58.4
1027
6173
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
155.3
58.1
61
*
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
+∞
56.4
54
*
9673/3-C77.9
ICD-O-3
Mantle cell lymphoma of lymph node, NOS
+∞
55.4
53
*
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
33.4
55.0
72
22
A04AD12
ATC
aprepitant; systemic
546.8
54.7
54
*
Z51.0
ICD-10 Finland
Radiotherapy session
280.8
54.3
55
*
Y77
ICPC
Malignant neoplasm prostate
189.8
54.1
56
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
536.5
53.7
53
*
1AA09
NOMESCO Finland
NA
+∞
53.3
51
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
53.3
51
*
TPX15
NOMESCO Finland
Removal of vascular injection port
46.5
52.4
64
14
C83.35
ICD-10 Finland
T-cell-rich B-cell lymphoma
+∞
52.2
50
*
C83.2
ICD-10 Finland
Mixed small and large cell (diffuse) non-Hodgkin's lymphoma
+∞
52.2
50
*
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
30.6
51.6
69
23
9823/3-C77.9
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph node, NOS
+∞
51.2
49
*
C83.71
ICD-10 Finland
Burkitt's tumour
+∞
51.2
49
*
390
Kela drug reimbursment
Ibrutinib
+∞
51.2
49
*
GD1AD
NOMESCO Finland
Thorax CT examination
4.3
51.1
202
498
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
179.5
51.0
53
*
WX110
NOMESCO Finland
Local anesthesy
1.8
50.5
1997
15472
JMA10
NOMESCO Finland
Transabdominal total splenectomy
33.6
50.5
66
20
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.5
50.4
428
1833
AA1BD
NOMESCO Finland
Extensive CT of head and brain
6.3
50.4
139
229
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
14.8
50.1
85
59
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
50.1
48
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
50.1
1014
6338
9680/3-C09.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of tonsil, NOS
+∞
49.1
47
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
49.1
47
*
9591/3-C77.2
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of intra-abdominal lymph nodes
+∞
49.1
47
*
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
50.0
49.0
59
12
WW200
NOMESCO Finland
Immunization
5.4
48.7
152
292
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
19.4
48.4
74
39
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
38.8
48.2
61
16
N02BE01
ATC
paracetamol; systemic, rectal
1.9
48.2
2689
23100
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
169.1
48.0
50
*
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
9.2
47.8
102
114
ZXE00
NOMESCO Finland
One hour or less
1.8
47.7
1246
8440
J01MA14
ATC
moxifloxacin; systemic
2.7
47.0
352
1398
9680/3-C77.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of head, face and neck
+∞
47.0
45
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
8.4
46.2
104
127
HAC20
NOMESCO Finland
Total mastectomy
67.2
46.2
53
8
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
45.9
44
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.9
45.6
308
1148
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
5.6
45.5
138
256
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
453.8
45.4
45
*
C90.0
ICD-10 Finland
Multiple myeloma
233.1
45.1
46
*
9673/3-C77.8
ICD-O-3
Mantle cell lymphoma of lymph nodes of multiple regions
+∞
44.9
43
*
9680/3-C16.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of stomach, NOS
+∞
44.9
43
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
44.1
1471
10646
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
228.0
44.0
45
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
228.0
44.0
45
*
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
30.0
44.0
59
20
L01BC06
ATC
capecitabine; oral
+∞
43.8
42
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
43.8
42
*
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
44.8
43.2
53
12
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.7
43.1
310
1202
NK6AN
NOMESCO Finland
Total body bone isotope imaging
39.2
42.9
54
14
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
42.8
41
*
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
42.7
1113
7468
H02AB09
ATC
hydrocortisone; systemic
5.5
42.3
129
241
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
422.9
42.2
42
*
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
38.5
41.9
53
14
1512
Kela drug reimbursment
Ibrutinib
+∞
41.7
40
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
41.7
40
*
C88.0
ICD-10 Finland
Waldenström macroglobulinaemia
+∞
41.7
40
*
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
212.6
40.9
42
*
C83
ICD-10 Finland
Non-follicular lymphoma
+∞
40.7
39
*
ED1AA
NOMESCO Finland
Mandipular X-ray examination
15.6
40.1
66
43
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.3
39.7
402
1873
L01BB05
ATC
fludarabine; systemic
+∞
39.7
38
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
39.7
38
*
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
19.7
39.6
60
31
2000A
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM FOLLICULARE]
+∞
38.6
37
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
38.6
37
*
L01XE27
ATC
[U] ibrutinib; oral
+∞
38.6
37
*
EMA10
NOMESCO Finland
Biopsy of tonsil
37.4
37.8
48
13
L57.0
ICD-10 Finland
Actinic keratosis
2.6
37.3
301
1245
HAB40
NOMESCO Finland
Wedge excision of mammary gland
18.7
37.0
57
31
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
131.5
36.8
39
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.5
36.6
134
307
C83.51
ICD-10 Finland
B-lymphoblastic lymphoma or leukemia
+∞
36.5
35
*
3AA13
NOMESCO Finland
NA
+∞
36.5
35
*
L02BG04
ATC
letrozole; oral
14.3
36.4
62
44
L02BA01
ATC
tamoxifen; oral
60.7
36.2
42
7
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
361.1
36.0
36
*
C03CA01
ATC
furosemide; systemic
1.7
36.0
1080
7456
J01DB01
ATC
cefalexin; oral
1.7
35.9
2446
20934
ZX131
NOMESCO Finland
Intrathecal
187.0
35.8
37
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
35.5
34
*
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
53.1
35.4
42
8
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.3
35.0
189
604
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
43.5
35.0
43
10
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
6.9
35.0
89
132
WX402
NOMESCO Finland
General anaesthesia
2.1
34.8
431
2190
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.2
34.7
196
646
C83.8
ICD-10 Finland
Other non-follicular lymphoma
+∞
34.4
33
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
34.4
33
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
34.4
33
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.8
34.2
673
4074
R06AE07
ATC
cetirizine; oral
1.6
34.0
1192
8552
UJF32
NOMESCO Finland
Coloscopy
1.7
33.9
798
5115
JFB00
NOMESCO Finland
Partial resection of small intestine
6.6
33.7
89
139
N02AX02
ATC
tramadol; systemic, rectal
1.6
33.6
1301
9568
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.3
33.5
128
306
9699/3-C16.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of stomach, NOS
+∞
33.4
32
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
33.4
32
*
C84.59
ICD-10 Finland
Other and unspecified T-cell lymphomas
+∞
33.4
32
*
Z51.3
ICD-10 Finland
Blood transfusion (without reported diagnosis)
+∞
33.4
32
*
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
+∞
33.4
32
*
9591/3-C77.4
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of inguinal region or leg
+∞
33.4
32
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
56.3
33.2
39
7
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
13.4
33.2
58
44
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
330.3
32.9
33
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
29.7
32.9
44
15
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
31.1
32.6
43
14
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
32.4
1156
8302
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
32.4
545
3121
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
+∞
32.3
31
*
9699/3-C77.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lymph node, NOS
+∞
32.3
31
*
9680/3-C62.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of testis, NOS
+∞
32.3
31
*
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
6.5
32.0
85
134
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
32.0
1163
8384
N05CF01
ATC
zopiclone; oral
1.6
32.0
1022
7122
KA1FN
NOMESCO Finland
Isotope renography
14.9
31.8
53
36
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
21.2
31.3
46
22
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
31.3
30
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
31.3
30
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
70.6
30.9
35
5
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
4.4
30.8
116
274
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
161.5
30.7
32
*
KFC00
NOMESCO Finland
Unilateral orchiectomy
16.6
30.6
49
30
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.0
30.4
125
320
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
7.0
30.3
76
111
9689/3-C42.2
ICD-O-3
Splenic marginal zone B-cell lymphoma of spleen
+∞
30.2
29
*
TQW99
NOMESCO Finland
Other minor procedure on skin
3.3
30.2
156
483
ZZR00
NOMESCO Finland
Flap of skin
9.8
30.1
61
63
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
15.5
29.9
49
32
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
3.0
29.8
176
599
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
5.8
29.7
86
152
V03AF03
ATC
calcium folinate; systemic
156.4
29.7
31
*
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
23.6
29.6
42
18
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
5.1
29.4
95
191
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
3.5
29.3
142
419
Z52.89
ICD-10 Finland
Donor of other organ or tissue
+∞
29.2
28
*
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
+∞
29.2
28
*
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
9.4
28.9
60
65
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
294.4
28.8
29
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
294.4
28.8
29
*
AAA10
NOMESCO Finland
Biopsy through craniotomy
151.3
28.7
30
*
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
13.0
28.3
50
39
B02.9
ICD-10 Finland
Zoster without complication
2.5
28.3
227
932
C83.59
ICD-10 Finland
Lymphoblastic lymphoma of indeterminate type
+∞
28.2
27
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
28.2
27
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
28.2
27
*
C88.9
ICD-10 Finland
Malignant immunoproliferative disease, unspecified
+∞
28.2
27
*
JAH00
NOMESCO Finland
Laparotomy
4.1
28.0
111
275
JN3AD
NOMESCO Finland
Abdominal CT examination
2.4
27.7
248
1080
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
42.9
27.7
34
8
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.2
27.7
307
1482
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
7.5
27.6
66
90
Z2446
NOMESCO Finland
Social worker
2.6
27.6
207
820
1CX01
NOMESCO Finland
NA
47.6
27.4
33
7
J02AC01
ATC
fluconazole; systemic
1.6
27.4
969
6873
Z3231
NOMESCO Finland
Registered nurse
1.6
27.2
821
5588
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
27.1
26
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
27.1
26
*
E83.50
ICD-10 Finland
Hypercalcemia
7.6
27.1
64
86
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
5.4
27.0
82
154
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
5.3
26.9
84
163
Z2221
NOMESCO Finland
Medical doctor
1.6
26.9
804
5456
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
9.2
26.7
56
62
127
Kela drug reimbursment
Transplant complication
6.3
26.6
72
117
R4190
NOMESCO Finland
Nutritional therapy
4.5
26.6
97
222
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
5.8
26.5
76
133
TGD00
NOMESCO Finland
Needle biopsy of lung
22.6
26.5
38
17
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
26.4
969
6921
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
9.6
26.4
54
57
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
4.2
26.2
102
249
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
52.1
26.2
31
6
4701
FHL
Neck lymph node removal
37.0
26.1
33
9
KCD02
NOMESCO Finland
Transurethral resection of bladder
12.9
26.1
46
36
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
+∞
26.1
25
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
26.1
25
*
9591/3-C77.1
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of intrathoracic lymph nodes
+∞
26.1
25
*
9690/3-C77.9
ICD-O-3
Follicular lymphoma, NOS, of lymph node, NOS
+∞
26.1
25
*
C80.99
ICD-10 Finland
Malignant tumor without specified localization or histology
+∞
26.1
25
*
GEA00
NOMESCO Finland
Mediastinoscopy
21.3
26.0
38
18
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
262.6
25.7
26
*
C50
ICD-10 Finland
Malignant neoplasm of breast
262.6
25.7
26
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.1
25.5
305
1518
9591/3-C16.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of stomach, NOS
+∞
25.0
24
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
25.0
24
*
C83.70
ICD-10 Finland
Non-Hodgkin's lymphoma of the Burkitt type
+∞
25.0
24
*
L01EL01
ATC
ibrutinib; oral
+∞
25.0
24
*
9698/3-C77.9
ICD-O-3
Follicular lymphoma, grade 3 of lymph node, NOS
+∞
25.0
24
*
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
5.2
24.9
78
152
A06AH03
ATC
naloxegol; oral
16.2
24.9
40
25
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
24.9
741
5008
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.2
24.9
136
440
SPAT1153
SPAT
Removal of sutures
1.6
24.8
927
6629
ZXD05
NOMESCO Finland
Urgent procedure
1.6
24.7
913
6510
JAH01
NOMESCO Finland
Laparoscopy
3.6
24.5
114
326
R4110
NOMESCO Finland
Physiotherapy
1.6
24.2
766
5250
WX002
NOMESCO Finland
Sedation and analgesia
1.7
24.2
615
3978
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
6.0
24.0
67
114
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
24.0
23
*
9680/3-C77.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of intra-abdominal lymph nodes
+∞
24.0
23
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
24.0
23
*
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
8.9
24.0
51
58
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.5
24.0
194
800
A41.8
ICD-10 Finland
Other specified sepsis
4.6
24.0
85
190
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
5.3
23.7
73
140
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
17.0
23.5
37
22
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.5
23.3
113
334
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
12.1
23.2
42
35
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
4.5
23.1
83
188
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
22.9
22
*
9591/3-C77.3
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of axilla or arm
+∞
22.9
22
*
C84.49
ICD-10 Finland
Peripheral T-cell lymphoma, unspecified cell type
+∞
22.9
22
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
22.9
22
*
9591/3-C09.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of tonsil, NOS
+∞
22.9
22
*
9591/3-C77.8
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of multiple regions
+∞
22.9
22
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
22.9
22
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
22.9
22
*
9691/3-C77.9
ICD-O-3
Follicular lymphoma, grade 2 of lymph node, NOS
+∞
22.9
22
*
A06AD11
ATC
lactulose; oral
1.8
22.5
466
2832
ZXA00
NOMESCO Finland
Right side
1.5
22.4
835
5940
J02AC03
ATC
voriconazole; systemic
45.3
22.3
27
6
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
4.5
22.1
80
183
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
35.3
22.0
28
8
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
21.9
21
*
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
+∞
21.9
21
*
C81.2
ICD-10 Finland
Mixed cellularity classical Hodgkin lymphoma
+∞
21.9
21
*
9680/3-C17.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of small intestine, NOS
+∞
21.9
21
*
C82.7
ICD-10 Finland
Other types of follicular lymphoma
+∞
21.9
21
*
C83.40
ICD-10 Finland
Immunoblast large cell lymphoma
+∞
21.9
21
*
PJ2HT
NOMESCO Finland
Biopsy of deep lymphnode with ultrasound guidance
+∞
21.9
21
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
21.9
21
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
21.9
21
*
WF099
NOMESCO Finland
Other radiotherapy
29.2
21.8
29
10
7856A
ICD-9 Finland
Symptoms involving cardiovascular system, Enlargement of lymph nodes
29.2
21.8
29
10
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
80.6
21.7
24
*
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
221.3
21.6
22
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
221.3
21.6
22
*
CAA30
NOMESCO Finland
Biopsy of orbit
115.8
21.6
23
*
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.0
21.4
128
439
J01MA02
ATC
ciprofloxacin; systemic
1.5
21.3
1151
8860
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.9
21.3
130
455
B01AB04
ATC
dalteparin; parenteral
2.6
21.1
164
662
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.5
21.0
166
676
1BC01
NOMESCO Finland
NA
+∞
20.8
20
*
372
Kela drug reimbursment
Idelalisib
+∞
20.8
20
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
+∞
20.8
20
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
+∞
20.8
20
*
N03AX16
ATC
pregabalin; oral
1.6
20.6
677
4660
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
211.2
20.6
21
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
211.2
20.6
21
*
B03XA02
ATC
darbepoetin alfa; parenteral
4.5
20.5
74
169
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
14.3
20.3
34
24
I88.9
ICD-10 Finland
Nonspecific lymphadenitis, unspecified
11.0
20.1
38
35
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
27.2
20.0
27
10
ZXC50
NOMESCO Finland
Cryotherapy
3.7
20.0
88
242
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
10.1
19.8
39
39
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
36.0
19.8
25
7
9680/3-C49.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of head, face, and neck
+∞
19.8
19
*
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
+∞
19.8
19
*
C85.0
ICD-10 Finland
Lymphosarcoma
+∞
19.8
19
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
+∞
19.8
19
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
19.8
19
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
19.8
19
*
JAH21
NOMESCO Finland
Staging laparoscopy
+∞
19.8
19
*
9680/3-C77.4
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of inguinal region or leg
+∞
19.8
19
*
C81.7
ICD-10 Finland
Other classical Hodgkin lymphoma
+∞
19.8
19
*
9680/3-C42.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of spleen
+∞
19.8
19
*
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
5.3
19.8
60
114
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.6
19.6
147
581
XX1AD
NOMESCO Finland
Other CT-examination
201.1
19.6
20
*
DAB10
NOMESCO Finland
Partial excision of auricle
201.1
19.6
20
*
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
17.8
19.5
30
17
J01CA04
ATC
amoxicillin; systemic
1.4
19.3
2276
20129
S18
ICPC
Laceration/cut
1.4
19.2
1177
9231
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
11.8
19.2
35
30
WX882
NOMESCO Finland
High dependency care
3.3
19.2
100
314
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
46.3
19.2
23
5
B74
ICPC
Malignant neoplasm blood other
46.3
19.2
23
5
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
18.8
18
*
C84.51
ICD-10 Finland
Other and unspecified T-cell lymphomas
+∞
18.8
18
*
C81.3
ICD-10 Finland
Lymphocyte depleted classical Hodgkin lymphoma
+∞
18.8
18
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
18.8
18
*
B73
ICPC
Leukaemia
+∞
18.8
18
*
9679/3-C38.3
ICD-O-3
Mediastinal large B-cell lymphoma of mediastinum, NOS
+∞
18.8
18
*
9699/3-C77.8
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
18.8
18
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
18.8
18
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
18.8
18
*
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
5.6
18.7
54
97
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
8.3
18.7
41
50
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
23.8
18.6
26
11
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
23.8
18.6
26
11
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
9.8
18.6
37
38
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
100.6
18.6
20
*
PA7ST
NOMESCO Finland
Extensive medical infusion to cerebral artery
191.0
18.5
19
*
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
14.2
18.5
31
22
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
6.5
18.5
48
75
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.1
18.5
106
355
A02BC01
ATC
omeprazole; systemic
1.5
18.4
835
6159
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
6.0
18.1
50
85
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
4.9
18.1
59
122
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.6
18.1
485
3158
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
18.0
599
4118
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
52.8
17.9
21
*
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
5.8
17.8
50
87
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
17.7
17
*
C83.52
ICD-10 Finland
T-lymphoblastic lymphoma or leukemia
+∞
17.7
17
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
17.7
17
*
C71.99
ICD-10 Finland
Malignant tumor in unspecified localization in the brain other or unspecified histology
+∞
17.7
17
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
17.7
17
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
66.9
17.7
20
*
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
20.1
17.7
26
13
120
Kela drug reimbursment
Hypogammaglobulinaemia
20.1
17.7
26
13
A02BA02
ATC
ranitidine; systemic
1.5
17.6
607
4205
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.2
17.5
183
859
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
6.2
17.5
47
77
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
180.9
17.5
18
*
R50.8
ICD-10 Finland
Other specified fever
11.5
17.5
32
28
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
15.7
17.5
28
18
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.5
17.4
83
244
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
3.6
17.3
78
220
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
9.5
16.9
34
36
9101
FHL
Bone biopsy
19.4
16.8
25
13
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.1
16.8
192
938
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
63.6
16.7
19
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
16.7
16
*
9680/3-C18.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of cecum
+∞
16.7
16
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
16.7
16
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
16.7
16
*
C83.6
ICD-10 Finland
Undifferentiated (diffuse) non-Hodgkin's lymphoma
+∞
16.7
16
*
C83.5
ICD-10 Finland
Lymphoblastic (diffuse) lymphoma
+∞
16.7
16
*
9673/3-C09.9
ICD-O-3
Mantle cell lymphoma of tonsil, NOS
+∞
16.7
16
*
9699/3-C34.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lung, NOS
+∞
16.7
16
*
9690/3-C77.8
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of multiple regions
+∞
16.7
16
*
C82
ICD-10 Finland
Follicular lymphoma
+∞
16.7
16
*
9699/3-C42.1
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of bone marrow
+∞
16.7
16
*
9698/3-C77.8
ICD-O-3
Follicular lymphoma, grade 3 of lymph nodes of multiple regions
+∞
16.7
16
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
16.7
16
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
16.7
16
*
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
+∞
16.7
16
*
9680/3-C34.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lung, NOS
+∞
16.7
16
*
D37.00
ICD-10 Finland
Aryepiglottic fold marginal zone
12.7
16.6
29
23
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
16.4
16.5
26
16
X76
ICPC
Malignant neoplasm breast female
170.8
16.5
17
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
170.8
16.5
17
*
ZXA05
NOMESCO Finland
Left side
1.5
16.5
755
5561
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
4.7
16.4
56
122
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
20.1
16.4
24
12
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
15.4
16.2
26
17
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.2
16.0
167
783
L01AA01
ATC
cyclophosphamide; systemic
11.7
16.0
29
25
TK800
NOMESCO Finland
Hemodialysis
3.2
15.8
82
258
J94.8
ICD-10 Finland
Other specified pleural conditions
4.0
15.8
63
160
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
11.2
15.7
29
26
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
33.5
15.7
20
6
JFB30
NOMESCO Finland
Right hemicolectomy
6.8
15.7
39
58
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.6
15.7
116
456
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
15.6
15
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
15.6
15
*
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
15.6
15
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
15.6
15
*
L01XX47
ATC
[U] idelalisib; oral
+∞
15.6
15
*
9761/3-C42.0
ICD-O-3
Waldenstrom macroglobulinemia of blood
+∞
15.6
15
*
L02BX02
ATC
degarelix; parenteral
+∞
15.6
15
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
15.6
15
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
15.6
15
*
9680/3-C77.3
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of axilla or arm
+∞
15.6
15
*
C84.43
ICD-10 Finland
Peripheral T-cell lymphoma, large cell type
+∞
15.6
15
*
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
15.6
15
*
C82.0
ICD-10 Finland
Follicular lymphoma grade I
+∞
15.6
15
*
9680/3-C22.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of liver
+∞
15.6
15
*
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
17.3
15.6
24
14
ZX121
NOMESCO Finland
Central venous catheter
26.4
15.6
21
8
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
26.4
15.6
21
8
L02BG03
ATC
anastrozole; oral
85.5
15.6
17
*
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
7.2
15.5
37
52
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
3.8
15.5
65
173
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
160.7
15.5
16
*
C44.10
ICD-10 Finland
Malignant tumor of the skin of the eyelids including the corner of the eye without histology
160.7
15.5
16
*
EBA10
NOMESCO Finland
Surgical removal of tooth
1.9
15.4
252
1410
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
15.3
938
7281
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.7
15.1
103
388
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
17.8
15.1
23
13
D37.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Stomach
6.9
15.1
37
54
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
3.7
15.1
66
182
XX3AT
NOMESCO Finland
Other labeling with ultrasound guidance
45.2
15.1
18
*
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
3.6
14.9
67
189
A05AA02
ATC
ursodeoxycholic acid; oral
4.4
14.9
53
121
UKC02
NOMESCO Finland
Cystoscopy
1.6
14.9
463
3125
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.4
14.8
124
522
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.1
14.8
163
782
5702
FHL
Local lymph node removal (eg armpit, groin)
31.8
14.8
19
6
B02
ICPC
Lymph gland(s) enlarged/painful
6.7
14.8
37
56
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
16.5
14.7
23
14
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
11.3
14.7
27
24
ZX114
NOMESCO Finland
Intramuscular
4.4
14.7
53
123
WX892
NOMESCO Finland
Monitored bed care
1.9
14.7
231
1278
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
3.6
14.6
66
187
XF400
NOMESCO Finland
ECG with 12 standard connections
1.5
14.6
521
3626
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
14.6
14
*
C84.0
ICD-10 Finland
Mycosis fungoides
+∞
14.6
14
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
14.6
14
*
9699/3-C07.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of parotid gland
+∞
14.6
14
*
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
+∞
14.6
14
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
14.6
14
*
9699/3-C69.6
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of orbit, NOS
+∞
14.6
14
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
14.6
14
*
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
+∞
14.6
14
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
14.6
14
*
C76.2
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Abdomen
+∞
14.6
14
*
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
+∞
14.6
14
*
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
+∞
14.6
14
*
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
14.6
14
*
I42.7
ICD-10 Finland
Cardiomyopathy due to drugs and other external agents
80.4
14.6
16
*
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
4.8
14.5
48
102
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
3.4
14.5
71
215
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
5.4
14.5
43
81
L02BG06
ATC
exemestane; oral
150.6
14.5
15
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
150.6
14.5
15
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
8.4
14.5
31
37
EMB10
NOMESCO Finland
Tonsillectomy
2.6
14.4
105
411
L04AD01
ATC
ciclosporin; systemic
3.6
14.2
64
181
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
8.2
14.2
31
38
ZYC01
NOMESCO Finland
Remote contact by phone
2.4
14.2
117
489
ZX050
NOMESCO Finland
Stereotactic radiotherapy
22.3
14.2
20
9
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
14.1
936
7352
JN4DD
NOMESCO Finland
Scout CT scan of torso
42.7
14.1
17
*
ENA10
NOMESCO Finland
Biopsy of pharynx
14.5
14.0
23
16
WX199
NOMESCO Finland
Other local analgesia
2.8
14.0
91
333
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
2.4
13.8
115
485
EP2AT
NOMESCO Finland
Neck soft tissue cytology with ultrasound guidance
17.6
13.8
21
12
D73.1
ICD-10 Finland
Hypersplenism
20.1
13.8
20
10
B99
ICD-10 Finland
Other and unspecified infectious diseases
3.2
13.6
72
231
XW4CT
NOMESCO Finland
Biopsy of other inner organ with CT guidance
75.4
13.6
15
*
8090/3-C44.1
ICD-O-3
Basal cell carcinoma, NOS, of eyelid
+∞
13.5
13
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
13.5
13
*
C16.20
ICD-10 Finland
Malignant tumor of the corpus ventriculi without histology
+∞
13.5
13
*
9663/3-C77.9
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph node, NOS
+∞
13.5
13
*
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
13.5
13
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
13.5
13
*
9591/3-C42.1
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of bone marrow
+∞
13.5
13
*
9680/3-C38.3
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of mediastinum, NOS
+∞
13.5
13
*
9691/3-C77.8
ICD-O-3
Follicular lymphoma, grade 2 of lymph nodes of multiple regions
+∞
13.5
13
*
9823/3-C77.8
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph nodes of multiple regions
+∞
13.5
13
*
399
Kela drug reimbursment
Venetoclax
+∞
13.5
13
*
R18
ICD-10 Finland
Ascites
4.1
13.5
52
129
HAB99
NOMESCO Finland
Other partial excision of mammary gland
6.3
13.5
35
56
PJ4AT
NOMESCO Finland
Labeling lymphnode with ultrasound guidance
140.5
13.5
14
*
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
7.4
13.4
31
42
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
3.1
13.4
71
229
JAL00
NOMESCO Finland
Biopsy of peritoneum
18.3
13.3
20
11
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
4.0
13.2
52
132
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
3.3
13.1
65
199
CFA20
NOMESCO Finland
Biopsy of conjunctiva
11.0
13.0
24
22
UJF30
NOMESCO Finland
Ileoscopy through colon
1.7
12.9
255
1520
ZQZ00
NOMESCO Finland
Treatment of several skin areas
22.6
12.9
18
8
A04AA03
ATC
tropisetron; systemic
50.2
12.8
15
*
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
50.2
12.8
15
*
PA7RT
NOMESCO Finland
Medical infusion to cerebral artery
50.2
12.8
15
*
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
50.2
12.8
15
*
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
4.0
12.7
50
127
N05BA06
ATC
lorazepam; systemic, sublingual
2.1
12.7
150
744
CBA10
NOMESCO Finland
Biopsy of eyelid
5.6
12.7
36
65
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
12.6
478
3361
L02AE03
ATC
goserelin; implant
12.3
12.6
22
18
Z51.88
ICD-10 Finland
Other specified medical care
3.2
12.5
64
201
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
12.5
12
*
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
12.5
12
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
12.5
12
*
C83.7
ICD-10 Finland
Burkitt lymphoma
+∞
12.5
12
*
PJ2CT
NOMESCO Finland
Biopsy of lymphnode with CT guidance
+∞
12.5
12
*
9663/3-C77.8
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of multiple regions
+∞
12.5
12
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
12.5
12
*
C91.7
ICD-10 Finland
Other lymphoid leukaemia
+∞
12.5
12
*
L02BB04
ATC
enzalutamide; oral
+∞
12.5
12
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
12.5
12
*
9680/3-C50.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of breast, NOS
+∞
12.5
12
*
1DB01
NOMESCO Finland
NA
+∞
12.5
12
*
9680/3-C49.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
12.5
12
*
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
+∞
12.5
12
*
C88.4
ICD-10 Finland
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lyphoma]
+∞
12.5
12
*
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
+∞
12.5
12
*
C83.41
ICD-10 Finland
Immunoblastic (diffuse)
+∞
12.5
12
*
C84.41
ICD-10 Finland
Peripheral T-cell lymphoma, medium-sized cell type
+∞
12.5
12
*
9695/3-C77.8
ICD-O-3
Follicular lymphoma, grade 1 of lymph nodes of multiple regions
+∞
12.5
12
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
12.5
12
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
12.5
12
*
9670/3-C77.9
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph node, NOS
+∞
12.5
12
*
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
11.0
12.5
23
21
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
11.0
12.5
23
21
GD6AD
NOMESCO Finland
CT of chest and neck
17.4
12.5
19
11
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
3.7
12.5
54
149
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
3.7
12.5
54
149
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
130.4
12.4
13
*
WX720
NOMESCO Finland
Own respiration
2.3
12.3
114
509
ZXC15
NOMESCO Finland
Use of photodynamic technique
5.2
12.2
37
72
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
37.7
12.2
15
*
ZXC40
NOMESCO Finland
Use of ultrasound
7.8
12.1
27
35
D10.4
ICD-10 Finland
Benign neoplasm: Tonsil
11.1
12.0
22
20
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
11.1
12.0
22
20
R05
ICD-10 Finland
Cough
1.5
12.0
512
3689
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
7.9
11.8
26
33
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
3.3
11.8
58
178
P01AB01
ATC
metronidazole; oral, rectal
1.3
11.8
969
7835
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.1
11.6
134
660
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
30.1
11.6
15
5
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.6
11.6
277
1740
6BA02
NOMESCO Finland
NA
12.6
11.6
20
16
ZXX04
NOMESCO Finland
Extent of procedure, 4 units
7.7
11.6
26
34
PA3AC
NOMESCO Finland
Carotis angiography with X-ray
7.7
11.6
26
34
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
65.2
11.6
13
*
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
19.0
11.6
17
9
ELB30
NOMESCO Finland
Excision of submandibular gland
6.5
11.5
29
45
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.9
11.5
170
920
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
11.5
11
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
11.5
11
*
L01XX52
ATC
venetoclax; oral
+∞
11.5
11
*
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
+∞
11.5
11
*
9680/3-C30.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of nasal cavity
+∞
11.5
11
*
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
+∞
11.5
11
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
11.5
11
*
WE100
NOMESCO Finland
Profylactic cytostatic therapy
+∞
11.5
11
*
2002A
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Burkitt's tumour or lymphoma
+∞
11.5
11
*
D73.0
ICD-10 Finland
Hyposplenism
+∞
11.5
11
*
2015X
ICD-9 Finland
Hodgkin's disease, Nodular sclerosis[MORBUS HODGKIN, NODULAR SCLEROSIS, NUD]
+∞
11.5
11
*
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
5.7
11.4
32
57
JAH20
NOMESCO Finland
Staging laparotomy
120.4
11.4
12
*
PJD99
NOMESCO Finland
Excision of other lymph nodes
120.4
11.4
12
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
4.5
11.4
39
87
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
2.4
11.3
93
391
L04AA06
ATC
mycophenolic acid; systemic
3.4
11.3
53
157
L03AA04
ATC
NA
35.1
11.3
14
*
EL4AT
NOMESCO Finland
Salivary gland cytology with ultrasound guidance
9.6
11.2
22
23
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
3.8
11.2
46
122
R11
ICD-10 Finland
Nausea and vomiting
1.8
11.1
195
1117
A07AA09
ATC
vancomycin; oral
3.6
11.1
48
133
K52.0
ICD-10 Finland
Gastroenteritis and colitis due to radiation
25.1
11.1
15
6
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
12.7
11.1
19
15
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
20.1
11.1
16
8
J01FF01
ATC
clindamycin; systemic
1.4
11.1
719
5584
RS220
NOMESCO Finland
NA
4.2
11.1
41
99
ZXE20
NOMESCO Finland
More than three and less than five hours
1.5
11.1
340
2281
WX704
NOMESCO Finland
Intubation
1.8
11.1
176
977
ZXC96
NOMESCO Finland
Robot assisted procedure
6.4
11.1
28
44
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.4
11.0
643
4907
C10AA07
ATC
rosuvastatin; oral
0.7
11.0
425
5742
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.9
10.9
150
794
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.5
10.8
84
346
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
10.6
10.8
20
19
PA4AC
NOMESCO Finland
Vertebralis angiography with X-ray
8.8
10.7
22
25
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
9.6
10.7
21
22
D73.9
ICD-10 Finland
Disease of spleen, unspecified
28.1
10.7
14
5
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
2.9
10.7
62
213
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
3.5
10.7
48
138
D75
ICPC
Malignant neoplasm colon/rectum
60.2
10.6
12
*
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
60.2
10.6
12
*
R93.8
ICD-10 Finland
Abnormal findings on diagnostic imaging of other specified body structures
8.0
10.6
23
29
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
3.5
10.6
47
134
B00.19
ICD-10 Finland
Other vesicular dermatitis caused by the herper simplex virus
7.0
10.5
25
36
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
14.2
10.5
17
12
A02BC05
ATC
esomeprazole; systemic
1.3
10.4
1076
8949
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
+∞
10.4
10
*
OAA41
NOMESCO Finland
Health check based on individual needs
+∞
10.4
10
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
10.4
10
*
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
+∞
10.4
10
*
9680/3-C17.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of duodenum
+∞
10.4
10
*
9699/3-C69.0
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of conjunctiva
+∞
10.4
10
*
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
+∞
10.4
10
*
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
+∞
10.4
10
*
3AX16
NOMESCO Finland
NA
+∞
10.4
10
*
C18.09
ICD-10 Finland
Malignant tumor of caecum other or unspecified histology
+∞
10.4
10
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
10.4
10
*
C16.00
ICD-10 Finland
Cardia
+∞
10.4
10
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
10.4
10
*
8090/3-C44.2
ICD-O-3
Basal cell carcinoma, NOS, of external ear
+∞
10.4
10
*
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
+∞
10.4
10
*
AAF30
NOMESCO Finland
Implantation of intraventricular injection device
+∞
10.4
10
*
L01CA04
ATC
vinorelbine; systemic
+∞
10.4
10
*
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
10.4
10
*
8070/3-C34.3
ICD-O-3
Squamous cell carcinoma, NOS, of lower lobe, lung
+∞
10.4
10
*
9680/3-C17.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of ileum
+∞
10.4
10
*
WX725
NOMESCO Finland
Noninvasive ventilation
2.1
10.4
115
558
XKD00
NOMESCO Finland
Uroflowmetry
1.5
10.3
436
3129
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.8
10.3
168
940
D37.08
ICD-10 Finland
Tumor of uncertain or unknown nature in other part of lip, oral cavity and pharynx
12.1
10.3
18
15
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
32.6
10.3
13
*
EB1BA
NOMESCO Finland
Extensive intraoral X-ray examination
7.1
10.3
24
34
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
18.8
10.2
15
8
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.7
10.2
194
1142
J35.1
ICD-10 Finland
Hypertrophy of tonsils
4.3
10.2
36
84
ZX100
NOMESCO Finland
Oral
3.8
10.2
41
108
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
13.1
10.1
17
13
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.4
10.1
473
3461
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
5.2
10.1
30
58
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
7.9
10.1
22
28
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
10.1
940
7700
J70.2
ICD-10 Finland
Acute drug-induced interstitial lung disorders
10.0
10.0
19
19
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
4.7
9.9
32
68
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.5
9.9
338
2320
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
2.5
9.9
77
315
L04AA01
ATC
[U] ciclosporin; systemic
3.2
9.9
50
158
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
12.2
9.8
17
14
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
5.0
9.8
30
60
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
9.8
1149
9707
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
3.0
9.8
56
191
D31.6
ICD-10 Finland
Benign neoplasm: Orbit, unspecified
13.4
9.7
16
12
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
5.3
9.6
28
53
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
55.1
9.6
11
*
KA3EB
NOMESCO Finland
Antegrade pyelography
10.0
9.5
18
18
B02
ICD-10 Finland
Zoster [herpes zoster]
2.1
9.4
104
506
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
100.3
9.4
10
*
EP3AT
NOMESCO Finland
Neck soft tissue biopsy with ultrasound guidance
100.3
9.4
10
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
100.3
9.4
10
*
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
30.1
9.4
12
*
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
4.3
9.4
33
77
8090/3-C44.7
ICD-O-3
Basal cell carcinoma, NOS, of skin of lower limb and hip
+∞
9.4
9
*
YJ1CD
NOMESCO Finland
Very extensive CT examination of abdomen for dose design of radiotherapy
+∞
9.4
9
*
2019X
ICD-9 Finland
Hodgkin's disease, unspecified
+∞
9.4
9
*
9689/3-C42.1
ICD-O-3
Splenic marginal zone B-cell lymphoma of bone marrow
+∞
9.4
9
*
JM2AT
NOMESCO Finland
Biopsy of spleen with ultrasound guidance
+∞
9.4
9
*
C69.60
ICD-10 Finland
Malignant tumor in orbit without histology
+∞
9.4
9
*
8130/3-C67.9
ICD-O-3
Papillary urothelial carcinoma of bladder, NOS
+∞
9.4
9
*
9673/3-C80.9
ICD-O-3
Mantle cell lymphoma of unknown primary site
+∞
9.4
9
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
9.4
9
*
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
+∞
9.4
9
*
Z08.2
ICD-10 Finland
Follow-up examination after chemotherapy for malignant neoplasm
+∞
9.4
9
*
C18.99
ICD-10 Finland
Malignant tumor in unspecified location in the colon other or unspecified histology
+∞
9.4
9
*
N74
ICPC
Malignant neoplasm nervous system
+∞
9.4
9
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
9.4
9
*
9670/3-C77.0
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of head, face and neck
+∞
9.4
9
*
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
+∞
9.4
9
*
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
+∞
9.4
9
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
9.4
9
*
6103
FHL
Staging laparotomy (to study the reticuloendothelial system)
+∞
9.4
9
*
C73.99
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology
+∞
9.4
9
*
20199
ICD-8 Finland
Hodgkin's disease
+∞
9.4
9
*
1CA02
NOMESCO Finland
NA
+∞
9.4
9
*
L02BX03
ATC
abiraterone; oral
+∞
9.4
9
*
9591/3-C17.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of small intestine, NOS
+∞
9.4
9
*
C90.2
ICD-10 Finland
Extramedullary plasmacytoma
+∞
9.4
9
*
C26.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the digestive system
+∞
9.4
9
*
9663/3-C77.0
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of head, face and neck
+∞
9.4
9
*
A03
ICPC
Fever
1.5
9.3
317
2174
N02AA01
ATC
morphine; systemic, rectal
4.2
9.3
34
82
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
7.3
9.2
21
29
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.0
9.2
115
588
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
4.5
9.1
31
70
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.5
9.1
348
2449
S77
ICPC
Malignant neoplasm of skin
11.5
9.1
16
14
ZX130
NOMESCO Finland
Epidural
8.3
9.0
19
23
AA5DR
NOMESCO Finland
Brain metabolism PET with CT
15.6
9.0
14
9
B59
ICD-10 Finland
Pneumocystosis
36.8
9.0
11
*
D47.7
ICD-10 Finland
Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
36.8
9.0
11
*
3AA02
NOMESCO Finland
NA
36.8
9.0
11
*
J70.4
ICD-10 Finland
Drug-induced interstitial lung disorders, unspecified
36.8
9.0
11
*
XG410
NOMESCO Finland
Flow-volume spirometry
2.0
9.0
112
572
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
3.9
9.0
35
90
N03AX14
ATC
levetiracetam; systemic
2.5
9.0
69
283
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
0.7
8.9
406
5362
I89.9
ICD-10 Finland
Noninfective disorder of lymphatic vessels and lymph nodes, unspecified
18.6
8.9
13
7
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.6
8.9
64
251
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
3.4
8.8
40
117
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.8
8.8
56
205
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
3.3
8.8
42
128
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
6.3
8.8
22
35
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.3
8.7
74
320
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.9
8.7
122
652
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
3.8
8.7
35
93
JN5AP
NOMESCO Finland
Total body PET (1 picture)
50.1
8.7
10
*
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
50.1
8.7
10
*
JN6CD
NOMESCO Finland
Very extensive CT of torso and neck
50.1
8.7
10
*
A21
ICPC
Risk factor for malignancy
50.1
8.7
10
*
N17.9
ICD-10 Finland
Acute renal failure, unspecified
1.9
8.7
116
611
S04
ICPC
Lump/swelling localized
1.6
8.6
206
1299
UJC01
NOMESCO Finland
Scopy of lower throat
4.5
8.6
29
65
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.9
8.6
131
720
CA1DG
NOMESCO Finland
Eye and orbita very extensive MRI examination with high intensity magnet
27.6
8.5
11
*
SPAT1088
SPAT
Blood transfusion
6.4
8.5
21
33
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
6.4
8.5
21
33
R59
ICD-10 Finland
Enlarged lymph nodes
20.1
8.5
12
6
1AA01
NOMESCO Finland
NA
20.1
8.5
12
6
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
2.3
8.5
74
324
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
8.4
384
2794
GA2AT
NOMESCO Finland
Pleural biopsy with ultrasound guidance
90.3
8.4
9
*
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
90.3
8.4
9
*
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
3.8
8.4
34
91
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.6
8.4
195
1218
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
2.6
8.4
59
232
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.5
8.4
66
1284
G04BE03
ATC
sildenafil; oral
4.8
8.4
26
54
2390A
ICD-9 Finland
Neoplasm of unspecified nature, Digestive system
7.9
8.3
18
23
G53.0
ICD-10 Finland
Postzoster neuralgia
4.1
8.3
31
77
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
4.1
8.3
31
77
3AF07
NOMESCO Finland
NA
+∞
8.3
8
*
C20
ICD-10 Finland
Malignant neoplasm of rectum
+∞
8.3
8
*
352
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
8.3
8
*
KA3CT
NOMESCO Finland
Biopsy of kidney under CT guidance
+∞
8.3
8
*
9699/3-C08.0
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of submandibular gland
+∞
8.3
8
*
9680/3-C07.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of parotid gland
+∞
8.3
8
*
8140/3-C18.0
ICD-O-3
Adenocarcinoma, NOS, of cecum
+∞
8.3
8
*
9680/3-C48.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of retroperitoneum
+∞
8.3
8
*
C69.00
ICD-10 Finland
Malignant tumor of the conjunctiva without histology
+∞
8.3
8
*
K62.7
ICD-10 Finland
Radiation proctitis
+∞
8.3
8
*
9680/3-C64.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of kidney, NOS
+∞
8.3
8
*
C18.40
ICD-10 Finland
Malignant tumor of the transverse colon without histology
+∞
8.3
8
*
9699/3-C44.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of skin, NOS
+∞
8.3
8
*
9670/3-C42.1
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of bone marrow
+∞
8.3
8
*
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
+∞
8.3
8
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
8.3
8
*
9591/3-C71.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of brain, NOS
+∞
8.3
8
*
17402
ICD-8 Finland
Malignant neoplasm of breast, Glandulae
+∞
8.3
8
*
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
8.3
8
*
9699/3-C80.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of unknown primary site
+∞
8.3
8
*
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
+∞
8.3
8
*
C83.4
ICD-10 Finland
Immunoblastic (diffuse) non-Hodgkin's lymphoma
+∞
8.3
8
*
C88.7
ICD-10 Finland
Other malignant immunoproliferative diseases
+∞
8.3
8
*
KE002
NOMESCO Finland
Radical radiotherapy of prostata and seminal vesicles
+∞
8.3
8
*
C80
ICD-10 Finland
Malignant neoplasm, without specification of site
+∞
8.3
8
*
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
+∞
8.3
8
*
9680/3-C49.3
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of thorax
+∞
8.3
8
*
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
+∞
8.3
8
*
9680/3-C49.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues, NOS
+∞
8.3
8
*
9591/3-C62.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of testis, NOS
+∞
8.3
8
*
C34.39
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology
+∞
8.3
8
*
C38.3
ICD-10 Finland
Malignant neoplasm: Mediastinum, part unspecified
+∞
8.3
8
*
20298
ICD-8 Finland
Other neoplasms of lymphoid tissue, Lymphomata alia
+∞
8.3
8
*
1518
Kela drug reimbursment
NA
+∞
8.3
8
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.8
8.3
127
701
D04.2
ICD-10 Finland
Carcinoma in situ: Skin of ear and external auricular canal
9.4
8.3
16
17
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
9.4
8.3
16
17
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
14.5
8.2
13
9
XF600
NOMESCO Finland
Bloodpressure measurement
1.7
8.2
175
1072
C10AA01
ATC
simvastatin; oral
0.8
8.1
1082
12483
ZXC20
NOMESCO Finland
Use of chemical agents
3.1
8.1
42
137
5701
FHL
Local exploration of lymph nodes (includes biopsy)
33.4
8.1
10
*
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
33.4
8.1
10
*
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
33.4
8.1
10
*
M05BA02
ATC
clodronic acid; systemic
22.1
8.0
11
5
KAC10
NOMESCO Finland
Total nephrectomy with capsule
22.1
8.0
11
5
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
8.0
381
2796
Z31.6
ICD-10 Finland
General counselling and advice on procreation
5.5
8.0
22
40
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
4.1
8.0
29
71
WW200
SPAT
NA
0.6
7.9
103
1747
B03XA01
ATC
erythropoietin; parenteral
4.0
7.9
30
76
E0000UV
ATC
NA
1.3
7.9
956
8051
M05BX04
ATC
denosumab; parenteral
2.0
7.9
101
520
D11.70
ICD-10 Finland
Gland sublingual
7.8
7.9
17
22
R93.4
ICD-10 Finland
Abnormal findings on diagnostic imaging of urinary organs
5.1
7.8
23
45
B04
ICPC
Blood symptom/complaint
5.1
7.8
23
45
CKA10
NOMESCO Finland
Biopsy of vitreous body
9.4
7.8
15
16
TKE00
NOMESCO Finland
Needle biopsy of prostate
2.2
7.7
77
358
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
45.1
7.7
9
*
JL1AT
NOMESCO Finland
Biopsy of pancreas with ultrasound guidance
45.1
7.7
9
*
J17.3
ICD-10 Finland
Pneumonia in parasitic diseases
45.1
7.7
9
*
JDE00
NOMESCO Finland
Gastrojejunostomy
18.4
7.6
11
6
NK6BN
NOMESCO Finland
Bone dynamic isotope examination
6.7
7.6
18
27
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.0
7.6
90
453
6753
FHL
Transabdominal splenectomy
11.9
7.6
13
11
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
3.9
7.5
29
75
H04.10
ICD-10 Finland
Dry eye syndrome
1.5
7.5
230
1541
A40.8
ICD-10 Finland
Other streptococcal sepsis
3.4
7.5
34
101
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.7
7.5
153
925
Z3226
NOMESCO Finland
Physiotherapist
1.4
7.5
463
3553
R53
ICD-10 Finland
Malaise and fatigue
1.3
7.5
519
4056
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.2
7.4
1088
9361
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
80.2
7.4
8
*
WF001
NOMESCO Finland
Preoperative radiotherapy
80.2
7.4
8
*
C44.50
ICD-10 Finland
Malignant tumor of the skin on the torso without histology
80.2
7.4
8
*
153
Kela drug reimbursment
Lenalidomid
80.2
7.4
8
*
B44.0
ICD-10 Finland
Invasive pulmonary aspergillosis
80.2
7.4
8
*
2301
FHL
Lumbar puncture in anesthesia or operating room
80.2
7.4
8
*
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.5
7.4
44
936
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
5.3
7.4
21
40
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
3.8
7.3
29
77
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
8.4
7.3
15
18
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.4
7.3
434
3306
8070/3-C44.2
ICD-O-3
Squamous cell carcinoma, NOS, of external ear
+∞
7.3
7
*
C81
ICD-10 Finland
Hodgkin lymphoma
+∞
7.3
7
*
9691/3-C77.0
ICD-O-3
Follicular lymphoma, grade 2 of lymph nodes of head, face and neck
+∞
7.3
7
*
C16.30
ICD-10 Finland
Malignant tumor of the antrum ventriculi without histology
+∞
7.3
7
*
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
+∞
7.3
7
*
V03AB28
ATC
NA
+∞
7.3
7
*
20013
ICD-8 Finland
Lymphosarcoma and reticulum-cell sarcoma, Lymphosarcoma loco alio (lymphonodis intrathoracalibus et intra-abdominalibus inclusis)
+∞
7.3
7
*
9680/3-C41.4
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of pelvic bones, sacrum, coccyx and associated joints
+∞
7.3
7
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
7.3
7
*
9671/3-C42.1
ICD-O-3
Lymphoplasmacytic lymphoma of bone marrow
+∞
7.3
7
*
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
7.3
7
*
L01AX03
ATC
temozolomide; systemic
+∞
7.3
7
*
C18.41
ICD-10 Finland
Malignant tumor of the transverse colon invasive carcinoma
+∞
7.3
7
*
WB323
NOMESCO Finland
Demanding adjuvant therapy of malignancy with biomodifiers
+∞
7.3
7
*
9705/3-C77.9
ICD-O-3
Angioimmunoblastic T-cell lymphoma of lymph node, NOS
+∞
7.3
7
*
9680/3-C01.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of base of tongue, NOS
+∞
7.3
7
*
C26.0
ICD-10 Finland
Malignant neoplasm: Intestinal tract, part unspecified
+∞
7.3
7
*
9680/3-C11.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of nasopharynx, NOS
+∞
7.3
7
*
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
+∞
7.3
7
*
8070/3-C00.1
ICD-O-3
Squamous cell carcinoma, NOS, of external lower lip
+∞
7.3
7
*
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
+∞
7.3
7
*
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
+∞
7.3
7
*
C91.4
ICD-10 Finland
Hairy-cell leukaemia
+∞
7.3
7
*
9695/3-C77.9
ICD-O-3
Follicular lymphoma, grade 1 of lymph node, NOS
+∞
7.3
7
*
C43.5
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of trunk
+∞
7.3
7
*
9690/3-C77.0
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of head, face and neck
+∞
7.3
7
*
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
+∞
7.3
7
*
C18.90
ICD-10 Finland
Malignant tumor in unspecified location in the colon without histology
+∞
7.3
7
*
9680/3-C73.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of thyroid gland
+∞
7.3
7
*
9680/3-C49.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
7.3
7
*
9687/3-C77.9
ICD-O-3
Burkitt lymphoma, NOS, of lymph node, NOS
+∞
7.3
7
*
9688/3-C77.8
ICD-O-3
T-cell/histiocyte rich large B-cell lymphoma of lymph nodes of multiple regions
+∞
7.3
7
*
C09.9
ICD-10 Finland
Malignant neoplasm: Tonsil, unspecified
+∞
7.3
7
*
C38.1
ICD-10 Finland
Malignant neoplasm: Anterior mediastinum
+∞
7.3
7
*
C71.20
ICD-10 Finland
Malignant tumor in temporal lobe without histology
+∞
7.3
7
*
9702/3-C77.9
ICD-O-3
Mature T-cell lymphoma, NOS, of lymph node, NOS
+∞
7.3
7
*
9670/3-C77.8
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of multiple regions
+∞
7.3
7
*
9680/3-C49.4
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of abdomen
+∞
7.3
7
*
9688/3-C77.9
ICD-O-3
T-cell/histiocyte rich large B-cell lymphoma of lymph node, NOS
+∞
7.3
7
*
C95.9
ICD-10 Finland
Leukaemia, unspecified
+∞
7.3
7
*
9680/3-C49.6
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
7.3
7
*
EMA30
NOMESCO Finland
Biopsy of rhinopharynx
9.4
7.3
14
15
B00.11
ICD-10 Finland
Herpes simplex labialis
3.5
7.3
32
93
ZXC95
NOMESCO Finland
Use of surgical navigator
3.2
7.3
35
109
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
0.8
7.3
445
5646
AA1AD
NOMESCO Finland
CT of head and brain
1.3
7.3
682
5556
J01AA02
ATC
doxycycline; systemic
1.2
7.2
2211
20552
GA3AT
NOMESCO Finland
Pleural cytology with ultrasound guidance
7.3
7.2
16
22
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
2.7
7.2
46
171
H53.2
ICD-10 Finland
Diplopia
2.1
7.2
78
380
EL3AT
NOMESCO Finland
Salivary gland biopsy with ultrasound guidance
30.1
7.1
9
*
JF1BD
NOMESCO Finland
Very extensive small bowel CT
4.8
7.1
22
46
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.4
7.1
416
3161
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.8
7.1
122
702
D10.6
ICD-10 Finland
Benign neoplasm: Nasopharynx
7.9
7.1
15
19
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
12.0
7.1
12
10
H26.3
ICD-10 Finland
Drug-induced cataract
4.5
7.1
23
51
QBA10
NOMESCO Finland
Incision of skin of trunk
4.5
7.1
23
51
P01BA02
ATC
hydroxychloroquine; oral
1.5
7.1
209
1394
J01MA01
ATC
ofloxacin; systemic
1.5
7.0
228
1551
ZZA50
NOMESCO Finland
Full thickness skin graft
8.8
7.0
14
16
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
8.8
7.0
14
16
SPAT1255
SPAT
Intravenous administration of medicine
1.6
7.0
159
992
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.6
7.0
184
1189
D86.0
ICD-10 Finland
Sarcoidosis of lung
3.0
7.0
38
129
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.5
7.0
199
1313
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.5
6.9
50
201
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
4.4
6.9
23
52
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
4.4
6.9
23
52
N06DX01
ATC
memantine; oral
0.6
6.9
82
1420
ZXE30
NOMESCO Finland
More than five and less than seven hours
1.8
6.9
111
625
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
5.5
6.9
19
35
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
3.4
6.9
31
92
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.0
6.9
79
395
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.3
6.9
446
3446
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
2.2
6.8
66
307
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.7
6.8
135
813
R93.3
ICD-10 Finland
Abnormal findings on diagnostic imaging of other parts of digestive tract
6.1
6.8
17
28
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.9
6.7
37
127
XQ848
NOMESCO Finland
Dermatological photography
2.4
6.7
54
229
D37.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Rectum
4.7
6.7
21
45
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
4.1
6.7
24
59
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
3.9
6.7
25
64
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
2.5
6.6
48
194
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
2.9
6.6
36
123
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.4
6.6
276
1978
N63
ICD-10 Finland
Unspecified lump in breast
2.0
6.6
83
430
EP1BG
NOMESCO Finland
MRI examination of soft tissue of neck with high intesity magnet
7.8
6.6
14
18
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
7.8
6.6
14
18
XJH00
NOMESCO Finland
Transanal ultrasonography
1.6
6.6
159
1007
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
12.3
6.6
11
9
ELB00
NOMESCO Finland
Excision or exploration of lesion of salivary gland
8.7
6.5
13
15
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
10.0
6.5
12
12
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
6.2
6.5
16
26
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
6.2
6.5
16
26
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
1.9
6.5
94
514
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
4.5
6.5
21
47
9690/3-C42.1
ICD-O-3
Follicular lymphoma, NOS, of bone marrow
70.0
6.4
7
*
WF090
NOMESCO Finland
Profylactic radiotherapy
70.0
6.4
7
*
J17.1*B25.0
ICD-10 Finland
Cytomegaloviral pneumonitis
70.0
6.4
7
*
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
70.0
6.4
7
*
PJA01
NOMESCO Finland
Laparoscopic sentinel node excision
70.0
6.4
7
*
9707
FHL
Ablation of mammae and removal of axillary lymph nodes
70.0
6.4
7
*
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
70.0
6.4
7
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
70.0
6.4
7
*
KFC10
NOMESCO Finland
Bilateral orchiectomy
70.0
6.4
7
*
A10BA02
ATC
metformin; oral
0.8
6.4
594
7168
KAD00
NOMESCO Finland
Partial nephrectomy
14.3
6.4
10
7
T80.8
ICD-10 Finland
Other complications following infusion, transfusion and therapeutic injection
14.3
6.4
10
7
R93.5
ICD-10 Finland
Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum
3.1
6.4
32
104
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
1.8
6.4
104
588
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
6.5
6.3
15
23
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
2.5
6.3
45
180
KA3GB
NOMESCO Finland
Retrograde pyelography
11.0
6.3
11
10
EL3AE
NOMESCO Finland
Salivary gland ultrasound examination
4.0
6.3
23
58
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
3.7
6.3
25
68
B37.7
ICD-10 Finland
Candidal sepsis
18.0
6.3
9
5
C01
ICD-10 Finland
Malignant neoplasm of base of tongue
+∞
6.2
6
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
6.2
6
*
8070/3-C44.5
ICD-O-3
Squamous cell carcinoma, NOS, of skin of trunk
+∞
6.2
6
*
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
+∞
6.2
6
*
Z92.3
ICD-10 Finland
Personal history of irradiation
+∞
6.2
6
*
C71.29
ICD-10 Finland
Malignant tumor in temporal lobe other or unspecified histology
+∞
6.2
6
*
9591/3-C69.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of eye, NOS
+∞
6.2
6
*
C23
ICD-10 Finland
Malignant neoplasm of gallbladder
+∞
6.2
6
*
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
+∞
6.2
6
*
C57.0
ICD-10 Finland
Malignant neoplasm: Fallopian tube
+∞
6.2
6
*
8720/3-C44.7
ICD-O-3
Malignant melanoma, NOS, of skin of lower limb and hip
+∞
6.2
6
*
9690/3-C77.4
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of inguinal region or leg
+∞
6.2
6
*
9680/3-C06.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of mouth, NOS
+∞
6.2
6
*
C84.4
ICD-10 Finland
Peripheral T-cell lymphoma, not elsewhere classified
+∞
6.2
6
*
8070/3-C34.1
ICD-O-3
Squamous cell carcinoma, NOS, of upper lobe, lung
+∞
6.2
6
*
C34.80
ICD-10 Finland
Malignant overall tumor of bronchus and lung without histology
+∞
6.2
6
*
C15.9
ICD-10 Finland
Malignant neoplasm: Oesophagus, unspecified
+∞
6.2
6
*
9673/3-C77.4
ICD-O-3
Mantle cell lymphoma of lymph nodes of inguinal region or leg
+∞
6.2
6
*
1744A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-outer quadrant
+∞
6.2
6
*
9673/3-C77.0
ICD-O-3
Mantle cell lymphoma of lymph nodes of head, face and neck
+∞
6.2
6
*
C50.50
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication
+∞
6.2
6
*
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
+∞
6.2
6
*
8041/3-C34.9
ICD-O-3
Small cell carcinoma, NOS, of lung, NOS
+∞
6.2
6
*
9680/3-C25.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of pancreas, NOS
+∞
6.2
6
*
C73.92
ICD-10 Finland
Follicular carcinoma of the thyroid gland
+∞
6.2
6
*
189
Kela drug reimbursment
Imatinib
+∞
6.2
6
*
C93.1
ICD-10 Finland
Chronic myelomonocytic leukaemia
+∞
6.2
6
*
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
+∞
6.2
6
*
C69.09
ICD-10 Finland
Malignant tumor in conjunctival other or unspecified histology
+∞
6.2
6
*
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
+∞
6.2
6
*
1AD01
NOMESCO Finland
NA
+∞
6.2
6
*
NFR30
NOMESCO Finland
Extended excision of soft tissue tumour of hip or thigh
+∞
6.2
6
*
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
+∞
6.2
6
*
U77
ICPC
Malignant neopl urinary tract other
+∞
6.2
6
*
9590/3-C77.9
ICD-O-3
Malignant lymphoma, NOS, of lymph node, NOS
+∞
6.2
6
*
C84.5
ICD-10 Finland
Other mature T/NK-cell lymphomas
+∞
6.2
6
*
9670/3-C77.3
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of axilla or arm
+∞
6.2
6
*
8070/3-C44.6
ICD-O-3
Squamous cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
6.2
6
*
Z08.1
ICD-10 Finland
Follow-up examination after radiotherapy for malignant neoplasm
+∞
6.2
6
*
C50.01
ICD-10 Finland
Malignant tumor of nipple and areola, ductal tumor
+∞
6.2
6
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
6.2
6
*
C34.89
ICD-10 Finland
Malignant overall tumor of the bronchus and lung other or unspecified histology
+∞
6.2
6
*
9691/3-C42.1
ICD-O-3
Follicular lymphoma, grade 2 of bone marrow
+∞
6.2
6
*
AAF35
NOMESCO Finland
Implantation of reservoir for intraventricular therapy
+∞
6.2
6
*
C17.2
ICD-10 Finland
Malignant neoplasm: Ileum
+∞
6.2
6
*
D76.1
ICD-10 Finland
Haemophagocytic lymphohistiocytosis
+∞
6.2
6
*
C92.9
ICD-10 Finland
Myeloid leukaemia, unspecified
+∞
6.2
6
*
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
+∞
6.2
6
*
1CB01
NOMESCO Finland
NA
+∞
6.2
6
*
C44.90
ICD-10 Finland
Unspecified localization of malignant tumor of the skin without histology
+∞
6.2
6
*
9591/3-C80.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of unknown primary site
+∞
6.2
6
*
9650/3-C77.1
ICD-O-3
Hodgkin lymphoma, NOS, of intrathoracic lymph nodes
+∞
6.2
6
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.6
6.2
141
878
A02BX02
ATC
sucralfate; oral
1.7
6.2
114
669
A01AB09
ATC
miconazole; local oral
1.5
6.2
214
1476
L02AE04
ATC
triptorelin; parenteral
26.7
6.2
8
*
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
4.1
6.2
22
54
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
3.1
6.2
31
101
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
3.8
6.2
24
64
I42.0
ICD-10 Finland
Dilated cardiomyopathy
1.8
6.1
91
499
K12.10
ICD-10 Finland
Stomatitis NOS
5.3
6.1
17
32
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.3
6.1
54
242
N02AA03
ATC
hydromorphone; systemic, rectal
12.5
6.1
10
8
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
4.9
6.0
18
37
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
10.0
6.0
11
11

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
190
50
40.06
311.37
3.5
1.5
u/l
54.8
48.9
0.07
180
43
(3022096) Basophils/100 leukocytes in Blood
2725
12214
6.05
307.65
11.0
5.7
%
0.7
0.7
0.07
2654
11230
(3021440) Promyelocytes/100 leukocytes in Blood
894
2112
5.30
307.65
6.4
3.9
%
0.2
0.1
3.82
578
444
(3005719) IgG [Mass/volume] in Serum or Plasma
1212
1802
9.63
307.65
4.3
2.2
g/l
8.7
10.8
35.02
1163
1634
(46235355) HIV 1 and 2 tests - Meaningful Use set
1750
2946
10.60
307.65
1.5
1.6
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
319
103
33.88
307.65
3.9
2.1
%
33.1
43.3
4.04
125
39
(21494814) CD8 cells/100 lymphocytes in Specimen
279
54
55.92
307.65
2.1
2.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
2938
14994
6.19
307.65
26.3
6.3
e9/l
3.5
4.3
73.81
2745
12831
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
400
402
11.07
307.65
2.3
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
477
634
8.52
307.65
1.7
1.5
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
2755
12619
6.02
307.65
11.8
6.0
%
9.7
8.9
25.15
2683
11628
(42870588) Differential panel, method unspecified - Blood
2366
9153
5.61
307.65
10.4
5.5
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
490
118
47.90
307.65
2.3
1.9
%
73.2
69.7
1.24
469
109
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
412
373
12.34
307.65
1.4
1.5
u/ml
115.4
110.6
0.25
105
67
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
479
551
9.87
307.65
2.3
1.4
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
2854
13889
6.07
307.65
10.7
5.5
e9/l
1.9
1.8
0.06
2643
12055
(3010503) CD19 cells [#/volume] in Blood
389
99
43.93
307.65
2.8
1.9
e9/l
0.2
0.1
0.51
383
94
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
486
113
49.56
307.65
2.3
1.9
%
14.8
14.6
0.04
194
55
(40768795) Lymph node Pathology biopsy report
808
61
170.45
307.65
1.4
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1678
2455
11.92
307.65
1.5
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
1007
2190
5.99
307.65
6.2
3.9
%
1.2
0.8
2.74
635
474
(3023368) Bacteria identified in Blood by Culture
1822
7764
3.72
307.65
8.3
3.9
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
2714
12774
5.55
307.65
10.5
5.6
%
56.3
57.8
6.87
2642
11763
(3045142) Bone marrow Pathology biopsy report
778
211
46.75
307.65
1.6
1.2
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
447
137
37.11
307.65
2.4
2.0
%
28.0
48.3
4.21
50
19
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
364
124
32.54
307.65
3.0
1.5
e6/l
575.8
432.6
2.36
302
108
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
476
109
50.16
307.65
2.4
2.0
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
542
289
21.90
307.65
2.6
2.6
u/ml
4750.9
592.4
1.43
42
20
(3028026) IgM [Mass/volume] in Serum or Plasma
868
1429
7.68
307.65
3.2
1.4
g/l
1.6
1.1
2.93
816
1286
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
462
430
12.18
307.65
1.4
1.5
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
348
133
28.86
307.65
3.3
1.5
e6/l
441.3
730.3
3.85
139
58
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
484
573
9.60
307.65
2.3
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
765
386
24.89
307.65
1.7
1.4
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
350
116
33.31
307.65
3.1
1.5
e9/l
0.2
0.2
0.15
302
106
(3021879) Hepatitis B virus core Ab [Presence] in Serum
1514
1353
18.57
307.65
1.4
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
881
2014
5.47
307.65
6.0
3.7
%
0.7
0.6
0.79
443
355
(3013115) Eosinophils [#/volume] in Blood
2871
14078
6.11
307.65
11.4
5.6
e9/l
0.2
0.2
29.15
2646
12200
(3026493) Urate [Moles/volume] in Serum or Plasma
2197
7949
5.52
307.65
6.2
2.5
umol/l
807.2
5888.3
15.22
2125
6744
(3001604) Monocytes [#/volume] in Blood
2842
13528
6.21
307.65
10.5
5.4
e9/l
0.6
0.6
0.09
2598
11545
(3024561) Albumin [Mass/volume] in Serum or Plasma
2486
11878
4.52
307.65
8.8
3.9
g/l
33.8
35.4
33.79
2400
10819
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
254
44
62.03
307.65
2.2
2.4
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
2744
12564
5.96
307.65
11.3
5.7
%
2.6
3.0
13.00
2674
11532
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
2365
2888
21.91
307.65
8.3
2.9
u/l
279.7
239.0
7.22
2309
2686
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
675
41
202.34
307.65
1.3
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
1041
2639
5.14
307.65
3.8
2.2
e9/l
69.7
68.8
0.32
878
2019
(3006245) CD3-CD19+ cells/100 cells in Blood
213
60
37.67
307.65
2.4
1.7
%
11.5
13.5
0.35
185
55
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2807
13622
5.80
307.65
15.7
3.9
umol/l
10.7
12.2
6.39
2769
12712
(3017143) Hepatitis C virus Ab [Presence] in Serum
1642
2216
12.77
307.65
1.5
1.6
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
2759
12895
5.86
307.65
11.6
5.8
%
27.1
27.1
0.00
2687
11806
(3027945) Reticulocytes/100 erythrocytes in Blood
1231
3482
4.85
307.65
3.8
2.2
%
1.8
1.8
0.34
1157
3042
(40765096) Chromosome analysis panel by Banding
254
42
64.99
307.65
1.2
1.0
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
2848
13622
6.20
307.65
10.5
5.4
e9/l
0.0
0.0
15.92
2605
11645
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
620
382
19.39
307.65
5.0
5.6
iu/ml
2701.8
488.8
0.48
97
57
(4035726)
1399
824
27.12
307.65
1.7
1.3
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
401
343
13.03
307.65
4.8
3.1
%
1.5
1.4
0.19
334
252
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1386
4182
4.76
307.65
7.2
2.6
mmol/l
0.8
0.8
7.09
1335
3828
(3011412) CD3 cells [#/volume] in Blood
594
158
44.82
307.65
2.7
1.8
e9/l
1.1
1.0
0.45
411
85
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
262
173
16.25
302.53
1.6
1.6
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1106
3650
3.93
286.11
7.1
5.6
mmol/l
1.0
1.0
0.59
1071
3351
(3004588) Protein electrophoresis panel - Serum or Plasma
815
2199
4.50
277.28
2.3
1.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2527
14273
3.58
272.64
12.7
5.8
mmol/l
1.2
1.2
6.57
2136
11978
(3025159) Blasts/100 leukocytes in Blood
760
2011
4.52
264.30
6.3
4.0
%
0.1
0.3
0.43
457
391
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
314
348
9.79
260.65
1.3
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
647
1528
4.94
259.05
2.3
1.4
ug/l
10.5
3.7
1.04
452
1134
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
2337
12911
3.30
254.52
11.0
5.4
mmol/l
1.2
1.2
4.68
2253
11413
(3000060) B lymphocytes [#/volume] in Blood
149
35
44.36
250.74
2.4
1.6
e6/l
646.7
197.3
0.55
52
22
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
332
416
8.69
250.21
1.3
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
338
439
8.39
247.26
1.9
1.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
832
2518
4.00
239.51
2.7
1.6
g/l
64.2
66.7
12.14
789
2236
(3015377) Calcium [Moles/volume] in Serum or Plasma
1817
8941
3.08
237.29
7.3
2.1
mmol/l
2.3
2.4
0.55
1694
7395
(3048929) Epstein Barr virus Ab [Presence] in Serum
373
579
7.07
232.85
1.4
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
296
352
9.07
232.35
1.9
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
698
1904
4.31
231.24
2.3
1.6
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
169
79
22.40
228.72
4.3
3.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1768
8707
3.02
228.18
2.6
1.7
—
—
—
0
0
(3018418) pH of Serum or Plasma
1694
8190
3.02
225.39
8.6
3.4
ph
7.4
7.4
0.99
415
1432
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1201
4794
3.26
223.47
2.9
1.8
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
252
256
10.51
222.47
5.4
3.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
1644
7873
3.00
221.68
4.6
2.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
289
354
8.79
221.42
1.8
1.3
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
300
385
8.41
221.26
1.3
1.3
u/ml
288.9
278.4
0.17
182
236
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2148
11946
2.98
218.65
7.2
3.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
252
264
10.19
217.55
1.9
1.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
237
228
11.06
217.29
2.4
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
246
250
10.49
217.05
2.3
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
1305
5588
3.09
213.61
9.8
4.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
454
934
5.42
211.76
2.3
2.8
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
142
60
24.60
199.81
3.8
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1204
5091
3.05
199.28
5.3
2.2
mmol/l
2.5
2.4
9.38
1161
4334
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
266
336
8.47
198.46
1.9
1.3
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
227
234
10.29
198.07
4.9
2.7
%
54.4
60.7
2.26
153
146
(40758558) Short blood count panel - Blood
1369
6314
2.88
192.02
19.4
4.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
277
389
7.63
188.70
2.0
1.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
3026
21306
3.62
186.59
20.4
5.4
u/l
83.7
76.6
12.70
2970
19664
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
115
32
37.09
185.07
1.4
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
313
521
6.48
181.83
1.5
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
191
175
11.47
180.68
2.6
2.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
204
209
10.29
178.61
1.3
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
185
168
11.55
176.00
1.3
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1298
6051
2.79
175.42
4.3
2.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
883
3343
3.17
174.36
2.6
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
881
3344
3.16
173.07
2.5
1.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
320
578
5.98
170.93
1.4
1.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
93
15
63.62
168.31
1.5
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
1078
4687
2.85
164.87
2.5
1.3
g/l
2.0
2.6
11.98
877
2667
(3021589) Normoblasts [#/volume] in Blood
2030
12049
2.57
164.15
19.1
8.6
e9/l
0.0
0.0
0.86
1738
9802
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
122
58
21.74
163.62
1.2
1.1
—
—
—
0
0
(44790049)
215
274
8.28
158.84
1.8
1.4
—
—
—
0
0
(44790048)
215
274
8.28
158.84
1.8
1.4
—
—
—
0
0
(44790047)
215
274
8.28
158.84
1.8
1.4
—
—
—
0
0
(44806118)
215
274
8.28
158.84
1.8
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
183
198
9.68
153.76
2.7
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
183
198
9.68
153.76
2.7
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
183
198
9.68
153.76
2.7
1.2
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
121
66
18.94
152.75
1.9
2.2
u/ml
5196.4
135381.5
—
16
10
(21494434) Karyotype in Bone marrow
193
228
8.89
151.56
1.2
1.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
439
1160
4.17
148.65
2.7
1.7
ug/l
2.7
1.6
0.82
409
992
(3033658) Prothrombin time (PT) actual/Normal
1306
6560
2.55
146.77
5.9
3.6
%
85.4
85.4
0.02
1277
6387
(3002256) Pathology report gross observation
619
2116
3.32
142.66
1.4
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
1974
12137
2.39
139.42
10.4
10.8
inr
1.2
1.4
7.64
540
3332
(3013707) Erythrocyte sedimentation rate by Westergren method
2883
21162
2.81
136.25
7.1
4.1
mm/h
16.9
12.5
29.92
2779
19386
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
114
70
16.79
135.85
3.1
1.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
113
70
16.63
134.05
3.1
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
113
70
16.63
134.05
3.1
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
274
552
5.29
129.37
2.0
1.9
u/ml
207.8
115.3
0.51
220
442
(3042936) Bacteria identified in Isolate by Culture
888
3915
2.68
128.01
2.0
2.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
116
85
14.07
125.68
1.4
1.3
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
978
4562
2.57
125.27
3.1
2.0
s
29.4
30.1
2.72
950
4417
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
381
1034
4.00
123.63
2.7
1.5
g/l
1.4
0.5
3.34
337
877
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
423
1242
3.73
122.57
2.6
1.4
g/l
7.3
7.4
0.91
330
909
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
369
985
4.06
122.47
2.7
1.6
mg/l
38.5
42.5
0.21
300
797
(3042631) Mycobacterium sp identified in Specimen
214
361
6.24
122.00
2.1
3.0
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
422
1241
3.72
121.98
2.6
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
421
1241
3.71
121.24
2.6
1.4
g/l
3.7
3.8
0.33
324
876
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
120
99
12.50
121.13
3.1
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
120
99
12.50
121.13
3.1
1.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
120
99
12.50
121.13
3.1
1.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
120
99
12.50
121.13
3.1
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
695
2779
2.86
120.34
4.6
2.3
umol/l
7.7
8.2
0.26
627
2396
(3034860) Kappa light chains.free [Mass/volume] in Serum
367
989
4.02
120.16
2.7
1.6
mg/l
58.0
50.7
0.59
301
804
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
355
953
4.02
116.76
2.7
1.5
ratio
7.5
2.7
0.37
22
82
(3032352) Blasts [#/volume] in Cerebral spinal fluid
123
9
141.44
115.88
1.8
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
396
1156
3.73
115.50
2.7
1.4
g/l
3.3
3.0
4.51
327
896
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
141
162
9.02
112.94
2.1
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
156
208
7.79
110.61
2.2
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
131
141
9.60
110.27
2.2
1.4
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
73
25
29.78
110.14
1.5
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
311
792
4.20
109.74
1.7
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
133
147
9.36
109.74
1.2
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
390
1166
3.63
109.59
2.6
1.4
g/l
9.5
10.4
2.54
352
968
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
130
140
9.60
109.38
2.2
1.4
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
282
672
4.47
108.51
3.4
2.5
g/l
3.8
3.5
1.84
273
642
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
337
918
3.95
108.39
2.6
1.5
g/l
0.1
0.0
0.35
323
834
(3013826) Glucose [Moles/volume] in Serum or Plasma
2405
17086
2.23
107.56
8.0
4.4
mmol/l
6.7
6.9
4.20
2339
15939
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
433
1420
3.33
105.15
2.1
1.6
g/l
1.6
1.5
0.41
361
1219
(40760888) Immunoglobulin light chains.free panel - Serum
283
723
4.16
99.23
2.7
1.5
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
306
841
3.88
96.94
2.8
1.5
g/l
0.0
0.0
0.00
296
770
(3002582) Erythrocytes [#/volume] in Urine
1421
8492
2.11
96.74
3.9
3.1
e6/l
35.6
71.7
2.29
1140
6498
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
308
856
3.84
96.01
2.8
1.5
g/l
0.0
0.0
0.50
296
773
(36304419) Bacteria [Presence] in Urine
1292
7474
2.14
95.55
3.8
2.9
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
1331
7792
2.12
95.37
3.8
3.0
e6/l
0.5
0.4
0.11
1043
5844
(3003694) ABO and Rh group [Type] in Blood
1189
6676
2.17
94.85
1.6
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
190
363
5.47
94.82
1.1
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
71
36
20.10
92.35
2.5
1.5
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
328
983
3.57
91.36
2.7
1.4
g/l
36.5
37.7
2.66
305
820
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
210
459
4.80
89.72
6.8
3.4
%
56.5
58.0
0.69
210
459
(3018095) Leukocytes [#/volume] in Urine
1561
9888
2.02
88.55
4.5
3.5
e6/l
137.7
104.6
0.33
1193
7008
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
181
352
5.36
88.52
6.0
6.4
mg/l
11.2
12.0
1.63
166
318
(3031040) Bacteria [#/volume] in Urine by Automated count
2472
18440
2.08
87.92
5.5
4.4
e6/l
1422.5
2285.8
0.35
46
299
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
260
698
3.94
84.94
1.9
1.2
mg/l
626.0
499.3
3.32
252
647
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
236
598
4.15
83.45
2.1
1.4
e6/l
8805.1
784.4
0.47
208
498
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
236
598
4.15
83.45
2.0
1.3
e6/l
23.5
28.0
0.11
204
473
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
103
118
8.96
82.58
1.7
1.4
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
86
5
176.14
82.50
1.1
1.0
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
786
3922
2.28
82.32
2.5
2.7
%
23.6
22.6
0.83
704
3283
(3044290) Cell count panel - Cerebral spinal fluid
221
539
4.30
82.19
2.0
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
304
931
3.47
81.68
3.4
3.3
u/ml
0.4
0.3
0.30
194
551
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
102
118
8.87
81.15
1.7
1.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
271
778
3.69
80.30
1.7
1.7
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
817
4220
2.21
78.21
2.4
2.6
g/l
2.2
2.3
9.32
768
3880
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
145
262
5.72
76.75
3.5
3.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
94
106
9.08
76.27
1.2
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
172
367
4.87
75.53
1.1
1.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
54
23
23.82
75.29
1.4
2.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
148
279
5.49
74.84
1.1
1.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
503
2139
2.57
74.68
2.2
2.1
g/l
0.2
0.2
2.51
465
1935
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
434
1718
2.74
74.41
1.8
1.5
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
854
4588
2.13
73.40
2.5
2.6
umol/l
12.9
12.9
0.03
806
4199
(3019832) Treponema pallidum Ab [Presence] in Serum
329
1132
3.10
72.86
1.4
1.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
538
2388
2.47
72.82
8.3
7.8
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
52
22
23.97
72.67
1.1
1.3
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
54
26
21.07
71.68
1.2
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
80
79
10.33
71.55
1.3
1.1
—
—
—
0
0
(3026782) Osmolality of Urine
963
5474
2.04
70.73
3.3
2.6
mosm/kgh2o
537.4
554.3
1.79
867
4578
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1209
7447
1.94
70.37
2.2
2.3
mg/l
3.4
2.9
5.31
1048
6284
(3000850) Epithelial cells [#/volume] in Urine
1024
5961
2.00
70.27
3.1
2.5
e6/l
3.8
4.7
2.88
926
5165
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
219
611
3.75
67.50
1.9
1.2
mmol/l
3.7
3.9
1.69
208
565
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1479
9848
1.85
66.74
3.7
3.1
ng/l
1854.8
1550.6
1.83
1357
8481
(3020779) Urea [Moles/volume] in Serum or Plasma
561
2650
2.32
65.57
7.8
7.1
mmol/l
10.3
10.9
1.16
546
2501
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
791
4369
2.04
61.80
3.3
2.8
e6/l
1.7
2.2
0.90
448
2381
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
172
432
4.13
61.37
1.3
1.2
miu/ml
129.0
209.4
1.44
30
168
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
494
2270
2.36
61.28
10.6
3.1
mmol/l
1.2
1.2
0.33
482
1932
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
61
51
12.15
60.88
1.7
1.1
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
226
699
3.38
59.47
2.0
1.9
mg/l
11.3
11.6
0.18
216
635
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
52
35
15.06
58.82
1.8
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
100
165
6.21
58.07
2.9
1.6
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
54
42
13.04
56.30
1.4
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
1276
8452
1.79
56.06
3.6
3.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
618
3225
2.11
55.73
1.8
1.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
573
2908
2.15
55.55
5.6
3.6
mmol/l
2.0
2.0
0.02
474
2356
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
130
287
4.66
54.71
1.2
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
824
4792
1.93
54.68
3.2
2.6
e6/l
1.0
1.2
0.79
477
2788
(3014576) Chloride [Moles/volume] in Serum or Plasma
665
3609
2.03
53.76
9.2
6.2
mmol/l
104.3
104.2
0.03
642
3518
(3003434) Protein [Mass/volume] in Pleural fluid
140
336
4.29
53.02
1.7
1.5
g/l
31.2
28.4
1.86
132
295
(3012544) pH of Venous blood
584
3038
2.10
52.89
5.6
3.6
ph
7.4
7.4
—
5
21
(3021447) Carbon dioxide [Partial pressure] in Venous blood
567
2920
2.12
52.72
5.7
3.6
kpa
5.7
5.8
2.42
556
2821
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
109
217
5.15
51.83
1.4
1.3
u/l
364.6
290.1
0.60
98
206
(3014111) Lactate [Moles/volume] in Serum or Plasma
510
2542
2.17
51.50
7.4
6.4
mmol/l
1.5
1.4
1.26
494
2434
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1306
8889
1.74
51.03
2.9
2.3
u/l
52.5
59.2
5.04
1212
8123
(3009343) pH of Capillary blood
424
1975
2.30
50.47
4.7
3.7
ph
7.4
7.4
1.85
58
230
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
413
1906
2.32
50.23
4.6
3.6
mmol/l
2.3
1.8
2.23
343
1372
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1547
11073
1.70
49.96
3.2
2.8
ug/l
400.6
139.3
21.60
1440
10098
(3037467) Urinalysis macro (dipstick) panel - Urine
2422
19530
1.73
49.92
5.4
4.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
426
2003
2.28
49.55
4.7
3.7
kpa
5.0
5.2
2.89
409
1838
(40768806) Pleura Pathology biopsy report
111
239
4.76
48.16
1.6
1.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
116
260
4.58
47.92
1.9
1.3
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
463
2285
2.18
47.74
2.1
1.8
nmol/l
371.4
364.5
0.31
443
2063
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
206
688
3.12
47.67
2.4
1.5
u/ml
98.7
28.0
2.57
198
656
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
385
1762
2.33
47.64
2.2
1.6
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
49
44
11.28
46.67
2.3
1.4
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
285
1152
2.60
46.17
1.9
1.8
u/l
43.1
38.1
2.84
254
975
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
39
24
16.42
46.12
2.9
1.1
u/ml
26.4
19.3
1.04
39
24
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
35
17
20.78
46.11
5.6
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
61
76
8.15
45.68
1.6
1.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1220
8352
1.70
45.41
6.4
2.7
u/l
36.0
36.4
0.05
1165
7847
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
131
338
3.98
45.02
2.1
1.8
u/ml
738.9
67.6
0.45
116
305
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
540
2896
2.02
44.44
6.1
3.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
125
315
4.07
44.37
2.7
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
125
316
4.06
44.18
2.7
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
125
318
4.04
43.80
2.7
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
179
581
3.19
43.44
2.3
1.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
110
257
4.38
43.13
1.7
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
928
5967
1.75
42.95
2.2
1.7
mg/l
2.0
1.3
2.93
755
4559
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
73
119
6.24
42.91
2.2
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
73
119
6.24
42.91
2.2
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
125
323
3.97
42.87
2.7
1.3
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
196
678
3.00
42.64
6.2
3.2
mg/l
1.5
1.7
1.34
181
605
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
124
321
3.96
42.42
2.7
1.3
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
319
1416
2.37
42.17
6.9
4.0
mmol/l
24.6
24.2
1.06
298
1252
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
286
1210
2.48
42.03
3.4
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
313
1380
2.39
42.01
1.4
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
125
328
3.91
41.97
2.7
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
105
242
4.44
41.89
1.1
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
112
272
4.22
41.77
1.1
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
74
127
5.93
41.31
3.0
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
85
167
5.19
41.04
2.1
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
184
628
3.03
40.97
1.2
1.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
446
2301
2.07
40.62
2.4
2.2
u/l
36.8
58.0
0.50
382
1940
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
83
163
5.19
40.09
2.1
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
931
6112
1.71
39.44
4.2
4.1
ng/l
319.4
500.2
0.45
813
5102
(3000012) Reticulocyte production index
83
169
5.00
38.48
1.4
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
565
3236
1.88
37.87
1.9
1.8
—
—
—
0
0
(3019225) pH of Specimen
525
2940
1.92
37.68
7.7
3.8
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
103
254
4.15
37.65
1.5
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
312
1442
2.27
37.45
5.2
3.8
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
80
163
5.00
37.07
1.3
1.3
u/l
32.7
10.5
1.40
75
145
(3036782) Glucose [Moles/volume] in Pleural fluid
92
215
4.36
36.08
1.5
1.3
mmol/l
6.1
6.9
1.66
85
196
(3023199) Leukocytes [#/volume] in Pleural fluid
110
301
3.74
34.81
1.6
1.5
e6/l
2074.9
1505.0
0.87
75
215
(3003396) Base excess in Arterial blood by calculation
576
3405
1.82
34.67
9.2
6.8
mmol/l
1.5
1.2
0.86
450
2618
(3028308) Erythrocytes [#/volume] in Pleural fluid
103
270
3.90
34.65
1.5
1.5
e6/l
25807.9
82942.9
1.03
58
159
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
47
60
7.92
34.49
1.0
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
3123
28059
1.85
33.88
39.6
13.6
mg/l
24.7
24.5
0.12
2915
21964
(3023419) Bacteria identified in Sputum by Culture
130
404
3.30
33.88
1.8
2.6
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
104
279
3.81
33.87
1.3
1.8
u/l
157.3
2959.9
2.06
27
110
(3009871) Measles virus Ab [Titer] in Serum
49
68
7.29
33.48
1.9
1.5
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
574
3431
1.80
33.19
9.2
6.7
kpa
12.2
11.6
2.19
548
3265
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
574
3432
1.80
33.15
9.2
6.8
kpa
5.0
5.1
1.17
543
3272
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
47
63
7.55
33.10
1.0
1.1
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
25
12
20.97
32.94
1.7
2.7
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1515
11572
1.53
32.79
2.4
2.2
nmol/l
78.6
78.5
0.03
1408
10104
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
252
1126
2.33
32.66
2.4
1.6
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
528
3105
1.82
32.15
9.8
7.0
%
95.9
95.0
3.55
508
2990
(3017732) Neutrophils [#/volume] in Blood
355
1835
2.04
31.85
3.1
3.2
e9/l
4.0
4.1
0.21
260
1316
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
32
27
11.95
31.64
1.2
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1554
12000
1.52
31.59
4.6
3.9
ng/l
40.7
77.4
1.20
1311
8861
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
267
1247
2.23
31.13
5.6
4.1
mmol/l
25.7
24.8
4.76
253
1143
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
154
558
2.84
30.78
1.4
1.5
—
—
—
0
0
(3036489) Thrombin time
215
926
2.41
30.26
3.3
2.0
s
22.8
21.2
1.90
202
822
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
170
658
2.66
29.94
3.9
2.3
%
226.8
192.3
4.32
161
628
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
68
148
4.66
29.18
1.2
1.3
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
67
146
4.66
28.71
3.3
5.8
u/ml
39.6
58.3
—
5
35
(3002173) Hemoglobin [Mass/volume] in Arterial blood
474
2792
1.80
28.49
10.6
7.4
g/l
111.8
122.2
21.36
455
2691
(3048879) Bone marrow aspiration report
43
62
7.01
28.40
2.0
1.2
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
93
262
3.62
28.24
1.5
1.4
g/l
0.3
0.4
2.02
64
189
(3028192) IgG subclass 2 [Mass/volume] in Serum
93
262
3.62
28.24
1.5
1.4
g/l
2.1
3.0
4.51
65
186
(3027135) IgG subclass 1 [Mass/volume] in Serum
93
262
3.62
28.24
1.5
1.4
g/l
6.0
6.9
1.00
63
188
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
124
419
3.03
28.11
1.1
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
89
246
3.68
27.80
2.6
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
160
630
2.61
27.23
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
160
630
2.61
27.23
1.5
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
60
125
4.86
27.14
1.4
1.3
—
—
—
0
0
(4062490)
91
261
3.55
26.91
1.5
1.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
121
416
2.97
26.62
1.5
1.7
g/l
0.5
0.9
4.83
85
320
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
67
161
4.22
25.41
1.4
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
23
16
14.46
25.35
1.3
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
23
16
14.46
25.35
1.3
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
23
16
14.46
25.35
1.3
1.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
157
640
2.52
24.89
3.9
3.9
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
93
287
3.30
24.57
1.9
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
594
3872
1.64
24.43
1.4
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
182
801
2.34
24.38
1.5
1.6
iu/ml
1.3
3.7
0.29
46
171
(40768793) Breast Pathology biopsy report
62
146
4.30
24.15
1.3
1.2
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
42
71
5.97
23.85
2.0
1.4
%
2.1
2.9
0.26
36
63
(3012501) Base excess in Blood by calculation
151
617
2.51
23.82
4.3
4.5
mmol/l
2.8
2.6
0.22
116
409
(40761536) Microorganisms panel - Urine sediment
377
2184
1.81
23.75
4.8
3.9
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
45
82
5.54
23.65
4.9
1.1
u/ml
38.8
67.2
0.39
11
23
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
121
447
2.77
23.36
1.2
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2029
17114
1.42
23.16
4.0
3.0
u/l
62.5
49.6
5.34
1888
15595
(3019060) Gas panel - Arterial blood
364
2106
1.81
23.01
7.9
4.7
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
79
231
3.47
22.73
1.5
1.5
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
56
128
4.43
22.67
1.5
1.1
%
66.6
52.2
0.51
11
13
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
46
89
5.22
22.66
1.9
1.3
%
66.4
62.7
0.25
39
74
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
280
1501
1.94
22.46
13.8
10.0
—
—
—
0
0
(3024471) HLA-A [Type]
42
77
5.51
21.94
1.0
1.0
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
27
31
8.77
21.53
1.1
1.3
mmol/l
3.4
4.4
0.14
20
16
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
23
22
10.52
20.89
1.2
1.1
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
41
78
5.31
20.59
1.3
1.1
%
16.3
33.0
—
14
8
(3010421) pH of Blood
162
733
2.27
20.37
4.3
4.4
ph
7.4
7.4
1.87
149
606
(3001686) Cold agglutinin [Titer] in Serum or Plasma
34
55
6.23
20.18
1.7
1.2
titre
45.0
64.0
—
7
8
(3024932) HLA-DR beta [Type]
40
76
5.31
20.12
1.4
1.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
120
477
2.57
20.09
1.7
1.4
u/l
10.5
8.8
0.75
104
391
(3024354) Oxygen [Partial pressure] in Venous blood
397
2448
1.70
19.98
5.6
3.0
kpa
4.7
4.5
0.58
385
2356
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
24
26
9.29
19.98
1.4
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
74
228
3.29
19.66
1.2
1.1
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
20
17
11.82
19.58
1.0
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
24
27
8.94
19.42
1.3
1.0
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
153
692
2.26
19.26
3.4
3.1
kpa
8.0
8.0
0.03
145
640
(3047189) Immunofixation for 24 hour Urine
50
119
4.25
19.26
1.6
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1664
13836
1.38
19.08
4.3
3.7
estimate
0.0
0.0
0.50
411
2376
(3021960) Folate [Moles/volume] in Serum or Plasma
978
7437
1.43
18.96
1.6
1.5
nmol/l
19.3
20.3
1.24
852
6264
(3015235) Bicarbonate [Moles/volume] in Capillary blood
170
810
2.15
18.83
3.1
3.1
mmol/l
24.3
24.9
0.84
155
714
(3022145) Colonoscopy Study observation
434
2780
1.64
18.83
1.4
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
131
565
2.37
18.42
3.1
2.8
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
24
29
8.32
18.38
1.3
1.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
215
1129
1.96
18.30
1.2
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
112
451
2.53
18.28
1.7
1.3
iu/l
28.9
28.7
0.02
93
387
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
260
1457
1.85
18.16
9.2
8.9
mmol/l
24.4
24.4
0.01
246
1326
(3049717) Cytology report of Urine Cyto stain
195
996
2.01
17.96
2.5
1.8
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
2535
22671
1.40
17.96
43.3
16.3
%
14.5
13.7
104.89
2510
22060
(3010375) cycloSPORINE [Mass/volume] in Blood
45
105
4.33
17.80
31.8
24.5
ug/l
106.5
120.6
0.72
38
83
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
64
193
3.36
17.62
1.1
1.0
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
160
770
2.13
17.29
1.7
1.5
g/l
0.2
0.2
0.86
145
728
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
162
784
2.12
17.26
1.7
1.5
g/l
1.1
1.2
1.73
156
736
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
20
21
9.57
17.00
3.5
6.5
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
20
21
9.57
17.00
1.8
3.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
164
808
2.08
16.68
4.0
3.6
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
135
616
2.24
16.67
3.4
2.5
%
14.6
16.4
6.24
77
335
(3021601) Nitrite [Presence] in Urine by Test strip
1645
13838
1.35
16.67
5.7
4.9
estimate
0.0
0.0
0.50
420
2413
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
35
70
5.04
16.66
1.9
1.1
ug/l
1.5
2.9
2.13
24
54
(3024891) Influenza virus A+B Ag [Presence] in Specimen
136
623
2.23
16.64
1.3
1.1
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
33
63
5.28
16.54
1.4
1.2
ug/l
1.4
95.2
0.93
14
26
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
49
130
3.81
16.34
1.1
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
1659
14007
1.34
16.25
4.4
3.7
estimate
0.0
0.0
0.11
405
2313
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
49
131
3.78
16.17
1.3
1.6
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
24
35
6.90
15.69
2.0
1.5
%
4.8
7.0
0.33
13
18
(3013512) EKG study
1129
9027
1.37
15.67
5.0
4.2
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
44
114
3.89
15.19
1.2
1.1
ng/l
2092.4
172.7
1.10
21
26
(3008152) Bicarbonate [Moles/volume] in Arterial blood
324
2033
1.65
15.15
10.9
6.7
mmol/l
24.9
24.5
0.79
302
1891
(3046861) Legionella sp Ag [Presence] in Urine
15
12
12.55
15.14
1.1
1.0
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
21
9
23.46
15.09
2.3
5.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
234
1345
1.79
15.03
2.6
3.0
pmol/l
4.2
4.5
3.89
211
1155
(3020393) Adenovirus Ag [Presence] in Stool
19
22
8.68
15.01
1.7
1.2
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
32
65
4.96
14.98
1.6
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
98
408
2.44
14.96
1.2
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
77
286
2.73
14.83
1.2
1.1
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
31
62
5.03
14.77
1.3
1.4
mmol/l
3.5
3.0
0.39
31
56
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
19
23
8.30
14.50
1.7
1.3
ng/l
117.4
129.9
0.14
11
11
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2604
28112
0.73
14.41
4.3
4.8
mmol/l
1.4
1.4
15.10
2326
25602
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
479
3331
1.51
14.32
1.3
1.4
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
265
1602
1.71
14.26
3.8
3.1
mmol/l
25.1
25.2
0.18
259
1541
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
245
1459
1.73
13.92
4.7
2.6
%
0.7
0.7
0.87
237
1389
(3026389) Candida sp identified in Specimen by Organism specific culture
84
339
2.51
13.73
1.4
1.3
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
55
177
3.14
13.70
1.2
1.1
mg/l
72.7
37.6
2.33
43
148
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2863
26523
1.39
13.60
33.1
12.7
ml/min/173m2
76.7
76.1
0.79
2605
21314
(3052592) Norovirus Ag [Presence] in Stool
29
59
4.95
13.56
1.7
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2635
28336
0.74
13.56
4.4
4.8
mmol/l
4.5
4.5
1.85
2380
25985
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
69
254
2.75
13.55
1.2
1.2
u/l
57.5
58.3
0.04
55
165
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
14
12
11.71
13.53
1.1
1.0
u/l
6.2
—
—
5
0
(3013862) HLA-DP [Type]
18
7
25.83
13.35
1.0
1.0
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
348
2293
1.57
13.28
3.7
3.9
ng/l
88.5
97.1
0.89
295
1934
(3044889) 12 lead EKG panel
2279
20452
1.31
13.16
5.0
4.1
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
186
1043
1.83
12.98
1.6
1.6
titre
435.0
270.2
—
7
55
(40768441) Liver Pathology biopsy report
39
104
3.78
12.97
1.1
1.4
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
39
104
3.78
12.97
1.9
1.2
g/l
1.6
0.1
—
8
8
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2711
28984
0.74
12.90
4.8
5.4
mmol/l
2.6
2.6
0.34
2418
26456
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
52
168
3.13
12.89
1.2
1.0
mg/l
424.6
270.8
1.70
44
148
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
24
43
5.61
12.88
13.0
2.3
umol/l
44.9
45.0
0.00
19
36
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
157
837
1.92
12.83
1.2
1.5
—
18.7
—
0
24
(3022217) INR in Platelet poor plasma by Coagulation assay
608
4520
1.42
12.73
26.8
29.3
inr
1.3
1.4
0.92
91
619
(40765089) Chromosome analysis panel - Blood by G-banded
18
24
7.53
12.69
1.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
17
7
24.38
12.45
1.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
17
7
24.38
12.45
1.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
17
7
24.38
12.45
1.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
17
7
24.38
12.45
1.0
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
73
289
2.56
12.45
3.3
3.8
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
45
136
3.34
12.44
1.1
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
70
272
2.60
12.40
1.3
1.1
u/ml
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2520
27174
0.76
12.25
5.8
6.5
mmol/mol
40.5
40.7
0.50
2266
24931
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
425
2975
1.49
12.22
3.2
3.1
ng/l
278.5
224.3
1.30
394
2753
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1686
14626
1.29
12.20
2.9
2.5
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
36
95
3.82
12.16
28.4
31.6
ug/l
7.0
7.5
0.85
29
86
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
22
39
5.67
11.94
1.8
1.2
ng/l
81.0
160.5
0.54
17
28
(3037121) Protein [Mass/volume] in Urine
171
961
1.82
11.87
2.8
2.6
g/l
0.7
0.3
0.68
85
340
(44786800) Granulocytes/100 leukocytes in Body fluid
17
23
7.42
11.84
1.4
1.3
%
20.7
19.5
0.04
11
15
(3047181) Lactate [Moles/volume] in Blood
166
934
1.81
11.49
12.0
6.2
mmol/l
1.3
1.3
0.04
140
831
(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
11
0
+∞
11.46
1.0
0.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
620
8011
0.73
11.43
1.7
1.7
mmol/l
1.4
1.4
1.51
528
6642
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
17
24
7.11
11.41
1.1
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
39
114
3.45
11.37
1.1
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
807
6391
1.34
11.27
1.8
1.8
nmol/l
1210.2
1159.6
0.77
640
4779
(3041918) Cholesterol [Moles/volume] in Pleural fluid
23
45
5.14
11.25
1.1
1.2
mmol/l
1.4
1.7
0.38
17
23
(3037522) Nuclear Ab [Titer] in Serum
491
3593
1.42
11.14
1.3
1.3
titre
745.7
524.2
1.16
109
788
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
15
6
25.09
11.13
1.5
1.2
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
14
16
8.78
11.11
1.0
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
49
169
2.93
10.91
1.4
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
44
143
3.10
10.85
1.1
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
42
134
3.16
10.68
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
42
134
3.16
10.68
1.1
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
65
263
2.50
10.65
1.1
1.1
—
29.1
—
0
7
(3006184) Hemoglobin [Mass/volume] in Capillary blood
131
701
1.90
10.64
2.7
2.2
g/l
119.3
130.8
5.12
96
517
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
47
161
2.94
10.60
1.2
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
334
2293
1.50
10.53
3.4
2.4
ml/min/173m2
58.7
62.8
1.02
134
888
(3023183) Ammonium ion [Moles/volume] in Plasma
116
602
1.96
10.33
2.5
2.6
umol/l
33.0
35.4
0.40
101
515
(3029937) Albumin [Presence] in Urine by Test strip
934
7635
1.30
10.26
5.0
4.1
estimate
0.0
0.0
0.32
391
2340
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
11
10
11.03
10.16
1.7
1.4
mg/l
1.9
4.1
—
5
5
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
26
62
4.22
10.08
1.1
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
41
134
3.08
10.04
5.2
4.4
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
234
1502
1.60
9.98
4.5
3.7
%
49.2
48.1
0.29
234
1480
(3020891) Body temperature
208
1300
1.64
9.90
6.1
4.7
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
20
39
5.15
9.83
1.3
1.3
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
187
1144
1.67
9.67
4.9
3.8
mmol/l
1.6
1.4
0.87
181
1122
(3019550) Sodium [Moles/volume] in Serum or Plasma
3128
29789
1.38
9.49
38.7
16.6
mmol/l
139.4
139.8
16.03
3088
28957
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
43
150
2.89
9.42
2.9
4.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
100
510
1.99
9.39
1.3
1.3
—
—
—
0
0
(40758358) Immune stain study
9
0
+∞
9.38
1.0
0.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
24
57
4.23
9.37
1.3
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
56
229
2.47
9.03
1.1
1.1
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
11
12
9.19
8.98
1.4
1.1
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
12
5
24.06
8.90
1.7
1.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
26
69
3.79
8.77
1.9
1.9
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2554
27187
0.79
8.76
4.0
4.3
mmol/l
1.3
1.3
2.45
2282
24537
(3051611) Lipemic interference index of Serum or Plasma
61
264
2.33
8.70
4.3
3.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
112
610
1.86
8.68
1.2
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
136
786
1.76
8.68
1.4
1.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
3128
29866
1.36
8.67
39.4
16.8
mmol/l
4.0
4.0
0.35
3084
28983
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1141
9726
1.25
8.64
2.2
2.2
u/l
163.5
217.8
1.87
1081
9070
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
18
36
5.02
8.61
1.5
2.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
135
781
1.76
8.59
1.4
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
38
131
2.92
8.53
1.3
1.1
u/l
1.2
1.1
0.44
22
58
(4027681)
38
131
2.92
8.53
1.3
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
273
1879
1.49
8.51
2.5
2.2
nmol/l
13.0
14.7
2.59
248
1635
(42529406) Shigella sp [Presence] in Stool by Culture
136
791
1.75
8.50
1.4
1.1
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
117
656
1.81
8.28
15.5
7.0
mmol/l
105.0
104.9
0.07
101
592
(3039000) Anion gap in Blood
117
656
1.81
8.28
15.5
7.0
mmol/l
10.7
11.3
1.26
101
592
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
99
527
1.90
8.25
1.3
1.2
u/l
96.8
30.1
2.44
86
460
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
202
1317
1.57
8.10
10.1
4.8
%
1.6
1.6
0.49
184
1239
(3022493) Free Hemoglobin [Mass/volume] in Plasma
38
135
2.83
8.10
1.4
6.3
mg/l
69.8
64.5
0.10
32
93
(3009542) Hematocrit [Volume Fraction] of Blood
2633
24682
1.25
7.76
34.7
15.1
%
37.1
39.6
29.94
1683
16033
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
25
71
3.54
7.69
1.1
1.0
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
11
6
18.38
7.59
1.1
1.0
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
11
6
18.38
7.59
1.1
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
24
67
3.60
7.57
2.9
1.4
—
—
—
0
0
(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum
11
15
7.35
7.55
1.3
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
108
609
1.80
7.54
1.1
1.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
196
1293
1.55
7.48
10.9
4.8
%
0.9
0.9
0.20
179
1219
(3035637) Corticotropin [Mass/volume] in Plasma
55
244
2.27
7.46
1.4
1.4
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
25
73
3.44
7.38
1.1
1.1
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
12
9
13.37
7.38
1.3
1.1
—
—
—
0
0
(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method
7
0
+∞
7.29
1.0
0.0
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3134
30071
1.32
7.28
24.1
9.4
u/l
26.9
25.9
1.37
3092
28690
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
29
94
3.10
7.27
1.1
1.1
miu/ml
905.1
1728.3
4.32
29
94
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
40
155
2.60
7.27
1.9
1.4
nmol/l
0.2
0.3
1.35
31
122
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
237
1638
1.48
7.26
1.3
1.3
au/ml
83.8
59.2
—
6
68
(3003327) Ova and parasites identified in Stool by Light microscopy
128
768
1.69
7.21
1.9
1.7
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
155
978
1.61
7.18
5.5
4.1
mmol/l
3.8
3.9
1.24
137
917
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1470
13112
1.20
6.73
2.1
2.1
pmol/l
91.0
93.9
1.49
860
6782
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
254
1809
1.43
6.67
2.5
2.4
au/ml
38.0
24.0
—
5
69
(3000570) Elastase.pancreatic [Mass/mass] in Stool
128
786
1.65
6.63
1.5
1.4
ug/g
251.3
286.7
1.21
79
475
(3003740) Influenza virus B Ag [Presence] in Specimen
55
257
2.16
6.62
1.2
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
34
130
2.63
6.38
1.1
1.1
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
64
322
2.01
6.37
1.2
1.2
u/ml
61.4
42.3
—
6
21
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
17
42
4.06
6.35
1.2
1.1
%
68.4
43.6
1.29
11
19
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
57
275
2.09
6.34
1.1
1.1
—
2.2
—
0
7
(3004716) Salmonella sp identified in Stool by Organism specific culture
166
1100
1.53
6.26
1.4
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
841
7140
1.23
6.26
4.2
3.3
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
25
82
3.06
6.18
1.3
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
805
6813
1.23
6.16
4.2
3.7
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
23
72
3.21
6.14
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
54
259
2.10
6.12
1.2
1.1
—
—
—
0
0
(3036603) Volume of Urine
38
158
2.42
6.02
1.6
1.4
ml
1819.9
1895.7
—
10
35
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
37
152
2.45
6.02
1.9
1.3
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
23
73
3.16
6.01
1.1
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
88
502
1.77
5.99
3.0
3.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
28
100
2.81
5.99
1.1
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
13
27
4.83
5.97
1.0
1.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
96
563
1.72
5.94
1.3
1.2
u/ml
1.4
6.7
—
7
47
(4281824)
33
131
2.53
5.77
1.1
1.2
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
14
32
4.39
5.76
1.6
1.8
—
—
—
0
0
(4212803)
12
24
5.01
5.74
1.2
1.0
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
55
274
2.02
5.66
1.3
1.4
mosm/kgh2o
272.9
277.8
1.08
48
208
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
9
7
12.89
5.58
1.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
36
152
2.38
5.55
1.9
1.3
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
215
1545
1.42
5.42
1.3
1.3
u/ml
539.3
248.6
0.95
186
1417
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
165
1128
1.48
5.41
2.0
2.3
ug/l
406.9
671.6
0.52
154
1062
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
8
5
16.04
5.41
1.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
19
58
3.29
5.30
1.2
1.1
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
3118
30119
1.26
5.28
42.2
15.9
umol/l
84.2
81.8
2.50
3118
30109
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
12
26
4.63
5.25
1.0
1.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1202
10715
1.18
5.17
4.7
3.9
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
762
8836
0.83
5.14
3.0
3.2
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
20
65
3.09
5.06
1.2
2.3
e6/l
14363.3
35653.1
0.31
15
35
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
33
141
2.35
4.98
1.5
1.3
—
—
—
0
0
(3019977) pH of Arterial blood
38
173
2.21
4.96
4.6
2.3
ph
7.4
7.4
0.12
13
69
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
116
1748
0.65
4.91
1.7
1.8
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
25
95
2.64
4.81
1.2
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
19
62
3.08
4.78
1.3
1.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
85
516
1.66
4.71
1.5
1.4
mmol/l
57.3
64.0
0.88
68
412
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
13
33
3.95
4.71
1.1
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
80
479
1.69
4.67
1.6
1.5
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
34
152
2.25
4.65
2.1
1.8
u/field
1.3
1.9
0.52
23
102
(3007566) Smooth muscle Ab [Titer] in Serum
107
690
1.57
4.65
1.2
1.2
titre
109.2
105.7
0.04
13
58
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
30
127
2.37
4.64
1.3
1.3
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
12
29
4.15
4.62
1.0
1.2
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
7
5
14.02
4.57
2.6
3.6
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
7
5
14.02
4.57
2.6
3.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
947
10673
0.85
4.53
4.0
4.0
mg/mmol
10.6
8.8
0.57
611
6791
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
21
76
2.77
4.44
1.1
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
3008
29057
1.21
4.40
29.6
13.4
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
7
6
11.69
4.27
1.0
1.0
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
103
676
1.54
4.18
1.4
1.2
u/ml
2.0
2.7
0.79
17
68
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
33
153
2.17
4.17
1.7
1.5
u/l
9.0
5.8
0.31
19
64
(3044242) Glucose [Moles/volume] in Arterial blood
37
180
2.07
4.15
1.9
1.7
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
65
381
1.72
4.14
1.2
1.2
u/ml
3.0
3.2
0.05
20
114
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
109
728
1.51
4.09
1.4
1.2
u/ml
44.8
47.9
0.06
14
40
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
12
32
3.76
4.08
1.3
1.7
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
222
2886
0.75
4.02
1.5
1.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
98
642
1.54
4.02
7.5
3.2
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
7
7
10.02
4.01
1.1
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
103
685
1.52
3.95
1.4
1.2
u/ml
2.0
5.8
1.61
21
117
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
25
106
2.37
3.90
3.4
2.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
63
376
1.69
3.79
1.1
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
13
39
3.34
3.76
1.1
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
173
1286
1.36
3.66
2.0
1.9
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
9
16
5.64
3.65
1.6
2.2
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
16
56
2.87
3.62
1.1
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
121
848
1.44
3.61
1.7
1.8
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
61
367
1.67
3.58
1.2
1.2
u/ml
3.1
5.8
1.62
25
161
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
22
93
2.37
3.48
2.4
2.3
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
79
511
1.56
3.48
1.3
1.2
u/ml
28.4
45.9
0.63
11
55
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
18
69
2.62
3.47
1.2
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
76
1151
0.65
3.39
1.4
1.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
21
88
2.39
3.39
6.8
2.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
21
88
2.39
3.39
6.8
2.7
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
19
76
2.51
3.37
1.2
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
13
42
3.10
3.37
1.7
1.6
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
32
3.44
3.33
1.0
1.0
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
103
713
1.46
3.31
3.1
3.2
nmol/l
1.0
0.8
0.70
74
546
(4268621)
44
248
1.78
3.27
2.1
2.3
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
101
700
1.46
3.23
1.2
1.2
—
1373.2
—
0
22
(3025130) Human papilloma virus identified in Specimen
34
178
1.92
3.18
2.1
1.8
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
62
388
1.61
3.16
3.0
2.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2218
21128
1.13
3.14
4.0
3.8
pmol/l
15.0
15.0
0.74
2008
18904
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
766
6820
1.16
3.12
1.7
1.7
pmol/l
18283467.7
36589291.5
0.45
629
5570
(3040151) Glucose [Moles/volume] in Capillary blood
58
359
1.63
3.10
6.1
27.9
mmol/l
7.5
7.5
0.06
50
292
(3012516) Albumin [Mass/volume] in Urine
915
10093
0.87
3.05
3.4
3.3
mg/l
1165.1
234.7
3.35
598
6459
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
52
834
0.62
3.04
1.5
1.7
mg/l
3.1
3.9
0.41
42
585
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
5
5
10.01
2.98
1.2
1.0
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
60
379
1.59
2.97
2.1
2.1
mg/l
29.8
24.6
0.31
18
89
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
12
40
3.01
2.97
1.1
1.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
15
59
2.55
2.78
1.5
2.3
—
—
—
0
0
(4015189)
21
97
2.17
2.76
1.3
2.8
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
5
6
8.34
2.75
1.2
1.2
mg/l
2.5
1.3
—
5
6
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
7
14
5.01
2.72
2.7
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
34
189
1.81
2.70
2.1
2.5
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
6
10
6.01
2.70
1.2
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
11
37
2.98
2.69
3.6
4.1
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
7
15
4.67
2.59
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
34
192
1.78
2.58
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
34
192
1.78
2.58
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
34
192
1.78
2.58
1.2
1.1
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
20
4.01
2.56
1.0
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
954
10396
0.89
2.55
3.2
3.2
mmol/l
7.1
7.5
1.93
786
8670
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
34
195
1.75
2.46
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
34
195
1.75
2.46
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
34
195
1.75
2.46
1.2
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
29
159
1.83
2.43
1.4
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
307
2591
1.20
2.41
4.4
3.4
—
—
—
0
0
(3014891) Appearance of Pleural fluid
10
34
2.95
2.41
1.3
1.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
16
70
2.29
2.41
1.1
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
15
64
2.35
2.38
1.2
1.9
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
28
153
1.84
2.38
1.2
1.7
umol/l
4.9
6.9
0.53
16
98
(3032743) Legionella sp IgG Ab [Presence] in Serum
7
17
4.12
2.36
1.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
7
17
4.12
2.36
1.0
1.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
120
1564
0.76
2.32
1.3
1.4
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
8
23
3.48
2.27
1.1
1.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
362
3129
1.17
2.19
2.3
2.4
ug/l
7.6
7.5
0.03
304
2720
(3002619) Bacteria identified in Specimen by Culture
12
48
2.51
2.18
1.6
1.2
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
6
14
4.29
2.15
1.0
3.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
36
221
1.64
2.08
12.1
2.1
%
10.5
11.0
0.26
36
221
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
32
191
1.68
2.06
1.3
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
339
2933
1.17
2.04
2.3
2.2
ug/g
203.7
159.1
0.91
284
2291
(40768446) Kidney Pathology biopsy report
20
104
1.93
2.00
1.1
1.6
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
7
21
3.34
1.96
1.0
1.0
—
—
—
0
0
(1002224) Polysomnography panel
67
924
0.72
1.94
1.1
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
28
164
1.71
1.94
1.0
1.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
8
27
2.97
1.93
1.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
6
16
3.75
1.93
1.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
47
316
1.49
1.88
1.1
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
181
1493
1.22
1.86
1.3
1.3
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
32
200
1.61
1.77
1.2
1.2
mmol/l
31.5
34.9
0.58
32
172
(3015171) Extractable nuclear Ab [Units/volume] in Serum
130
1043
1.26
1.73
1.4
1.2
u/ml
6.7
1.1
—
7
99
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
48
331
1.46
1.72
1.1
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
42
282
1.50
1.71
1.0
1.0
u/ml
1.6
2.8
1.28
12
101
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
42
612
0.68
1.70
1.2
1.5
nmol/l
1.0
0.8
0.54
33
505
(3017569) Oxygen content in Arterial blood
29
180
1.62
1.66
1.8
1.7
—
—
—
0
0
(3016750) Collection duration of Urine
31
196
1.59
1.65
2.2
2.1
min
517.2
489.9
0.91
15
144
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
5
14
3.57
1.61
1.0
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
42
604
0.69
1.60
1.6
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
189
1594
1.20
1.59
3.7
3.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
24
144
1.67
1.57
2.1
2.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
13
64
2.03
1.54
1.4
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
104
829
1.26
1.50
4.7
4.0
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
89
696
1.29
1.50
4.6
3.0
mmol/l
7.0
7.7
2.11
89
675
(3038177) Helicobacter pylori Ab [Presence] in Serum
50
358
1.40
1.50
1.1
1.3
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
7
28
2.50
1.45
6.3
4.5
ug/min
42.4
44.7
—
7
21
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
5
16
3.13
1.44
1.2
3.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
394
4370
0.89
1.42
1.2
1.2
u/ml
11.9
14.6
0.32
127
1604
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
22
348
0.63
1.37
1.0
1.1
u/ml
14.3
1.9
—
6
148
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
5
17
2.94
1.36
1.2
1.5
ml/s/173m2
1.7
0.8
—
5
12
(3017315) Amylase [Enzymatic activity/volume] in Urine
23
143
1.61
1.35
1.3
1.2
u/l
149.8
339.0
1.64
23
128
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
98
1211
0.80
1.35
1.1
1.1
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
92
735
1.26
1.34
4.4
2.9
mmol/l
1.6
1.7
0.73
92
713
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
20
120
1.67
1.34
1.2
1.2
ratio
1.2
1.1
—
7
39
(3024731) MCV [Entitic volume]
3159
31160
1.11
1.32
52.7
20.0
fl
92.1
91.4
13.52
3127
30559
(3035941) MCH [Entitic mass]
3159
31162
1.11
1.31
52.6
20.0
pg
30.5
30.5
1.63
3127
30563
(3026361) Erythrocytes [#/volume] in Blood
3159
31164
1.11
1.30
52.9
20.1
e12/l
4.2
4.5
182.36
3092
30033
(3007461) Platelets [#/volume] in Blood
3158
31154
1.11
1.30
53.0
20.1
e9/l
216.0
242.4
71.98
3097
30154
(3010813) Leukocytes [#/volume] in Blood
3159
31169
1.11
1.28
52.9
20.1
e9/l
6.7
6.8
0.39
3094
30037
(3000963) Hemoglobin [Mass/volume] in Blood
3159
31171
1.11
1.27
53.1
20.2
g/l
124.7
136.4
244.77
3126
30570
(3037556) Urate [Mass/volume] in Serum or Plasma
5
116
0.43
1.25
1.2
1.3
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
15
85
1.77
1.22
1.4
1.3
—
—
—
0
0
(4306422)
48
356
1.35
1.22
1.3
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
48
356
1.35
1.22
1.2
1.1
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
5
19
2.63
1.21
1.0
1.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
8
37
2.16
1.21
1.1
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
36
256
1.41
1.17
2.3
2.1
u/field
2.1
1.8
0.15
16
93
(44816559) Phosphatidylethanol [Mass/volume] in Blood
35
485
0.72
1.15
1.5
1.3
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
15
87
1.73
1.15
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
15
87
1.73
1.15
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
15
87
1.73
1.15
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
15
87
1.73
1.15
1.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
34
473
0.72
1.15
1.4
1.5
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
46
343
1.35
1.14
1.0
1.1
g/l
1.7
1.5
2.06
46
294
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
8
156
0.51
1.13
1.3
1.3
—
—
—
0
0
(44806420)
5
113
0.44
1.12
2.2
2.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
82
663
1.24
1.12
2.3
2.2
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
28
192
1.46
1.11
1.5
1.5
umol/l
15.6
13.9
0.57
28
176
(3008401) Mugwort IgE Ab [Units/volume] in Serum
19
293
0.65
1.10
1.0
1.1
u/ml
2.7
1.7
—
5
128
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
12
67
1.79
1.04
1.1
1.1
%
73.7
86.4
—
7
31
(36660697) Celiac disease serology panel - Serum
226
2011
1.13
1.03
1.2
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
37
273
1.36
1.00
1.9
1.5
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
20
298
0.67
1.00
1.0
1.1
u/ml
12.4
5.0
—
7
152
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
12
68
1.77
1.00
1.1
1.1
%
78.0
89.5
—
7
33
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
113
958
1.19
0.99
1.6
1.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
68
548
1.25
0.98
1.3
1.4
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
31
223
1.39
0.98
1.2
1.2
—
131.4
—
0
7
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
29
0.00
0.97
0.0
1.1
—
32.0
—
0
22
(3034426) Prothrombin time (PT)
14
84
1.67
0.97
1.2
1.3
—
—
—
0
0
(4034850)
88
1053
0.83
0.95
12.7
10.4
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
80
659
1.22
0.95
1.1
1.1
u/ml
4.5
8.4
—
10
52
(4146454)
29
399
0.72
0.95
2.7
2.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
187
1655
1.14
0.94
2.4
2.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
442
4099
1.09
0.94
13.0
7.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
21
142
1.48
0.92
1.1
1.2
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
24
167
1.44
0.92
1.9
2.0
mmol/l
8.9
9.5
0.60
18
131
(3051387) C reactive protein [Mass/volume] in Capillary blood
80
664
1.21
0.90
4.0
3.6
mg/l
25.8
29.2
0.52
55
433
(3022621) pH of Urine by Test strip
216
1938
1.12
0.89
3.1
3.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
104
1216
0.85
0.88
1.3
1.7
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
40
516
0.77
0.87
1.6
1.4
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
6
30
2.00
0.87
1.2
1.4
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
6
31
1.94
0.84
1.8
2.4
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
6
32
1.88
0.81
1.0
1.0
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
19
272
0.70
0.81
1.0
1.0
ng/l
44.0
47.4
0.31
13
170
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
19
272
0.70
0.81
1.0
1.0
ng/l
768.7
693.9
0.23
14
170
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
29
215
1.35
0.80
1.4
1.2
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
19
270
0.70
0.78
1.0
1.0
ng/l
321.1
337.3
0.13
14
173
(4024509)
40
314
1.28
0.76
1.3
1.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
19
132
1.44
0.75
1.2
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2781
28168
0.94
0.75
5.0
5.0
mmol/l
6.0
6.1
2.65
2516
25348
(3026480) Teichoate Ab [Titer] in Serum
5
24
2.08
0.74
1.0
1.0
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
7
38
1.84
0.73
1.4
1.6
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
5
25
2.00
0.72
1.0
1.2
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
7
40
1.75
0.71
7.6
12.4
mmol/l
8.8
5.3
—
7
40
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
19
134
1.42
0.71
1.4
1.3
mmol/l
6.0
6.2
0.20
19
127
(4010399)
199
2189
0.90
0.71
1.4
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
579
5492
1.06
0.71
1.2
1.3
u/ml
2.1
2.0
0.09
126
1420
(3009466) Valproate [Moles/volume] in Serum or Plasma
34
431
0.79
0.68
3.4
4.5
umol/l
304.4
356.0
1.22
27
369
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
10
61
1.64
0.68
2.8
3.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
66
780
0.84
0.68
1.6
1.7
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
30
231
1.30
0.67
1.3
1.1
u/ml
75.5
97.3
—
6
11
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
16
111
1.44
0.65
3.0
2.6
umol/l
26.6
29.9
0.58
11
82
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
36
286
1.26
0.65
1.4
1.4
%
34.1
27.2
0.48
24
187
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
8
127
0.63
0.64
1.3
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1300
12641
1.04
0.62
4.7
3.9
ug/l
2.9
2.4
0.62
1142
11349
(3045683) HLA typing for celiac disease panel - Blood or Tissue
17
121
1.41
0.62
1.0
1.0
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
36
446
0.81
0.61
1.1
1.1
iu/ml
1.2
416.4
—
5
91
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
121
1354
0.89
0.61
1.4
1.8
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
42
343
1.23
0.61
1.5
1.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
17
122
1.40
0.60
1.1
1.1
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
10
64
1.56
0.58
1.2
2.0
mmol/l
1.2
1.2
—
10
64
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
8
53
1.51
0.58
1.0
1.0
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
38
309
1.23
0.58
1.6
1.3
e6/l
13959.6
166680.1
2.51
28
215
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
113
0.62
0.58
3.1
1.6
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
6
35
1.72
0.57
2.0
2.0
umol/l
20.3
19.5
—
6
35
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2627
25953
1.05
0.57
4.8
4.6
mu/l
3.1
2.1
0.48
2388
23369
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
157
1431
1.10
0.55
1.2
1.2
iu/ml
137.5
127.3
0.09
43
532
(3029075) Extractable nuclear Ab panel - Serum
10
65
1.54
0.55
1.1
1.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
38
461
0.82
0.55
1.2
1.8
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
23
177
1.30
0.54
2.4
3.0
—
—
—
0
0
(3000492) Spirometry study
261
2437
1.08
0.54
1.6
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
16
216
0.74
0.53
1.2
2.4
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
10
147
0.68
0.53
1.7
1.4
—
1.5
—
0
13
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
38
459
0.83
0.53
1.2
1.7
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
6
97
0.62
0.52
2.8
2.6
nmol/l
130.2
152.7
—
6
83
(3006462) Nitrate [Presence] in Urine
18
135
1.34
0.51
2.8
3.5
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
9
65
1.39
0.50
1.1
1.3
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
12
168
0.71
0.50
1.5
1.3
nmol/l
1.3
1.2
—
6
128
(3000764) Benzodiazepines [Presence] in Urine
39
466
0.84
0.50
1.2
1.9
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
174
1880
0.92
0.47
1.2
1.2
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
7
47
1.49
0.47
1.0
1.2
—
79.8
—
0
13
(4211845)
19
147
1.29
0.45
2.7
3.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
443
4628
0.95
0.44
1.2
1.3
iu/ml
53.0
38.7
0.73
142
1410
(3016879) Cocaine [Presence] in Urine
37
438
0.84
0.44
1.2
1.9
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
14
104
1.35
0.43
1.2
2.4
umol/l
108.1
128.3
—
9
61
(3001729) Color of Synovial fluid
5
31
1.61
0.43
1.6
1.3
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
5
31
1.61
0.43
1.0
1.2
umol/24h
2.1
1.7
—
5
31
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
6
91
0.66
0.42
1.3
1.5
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
5
32
1.56
0.42
2.0
2.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
40
467
0.85
0.41
1.1
1.9
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
10
70
1.43
0.41
1.3
1.6
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
266
2809
0.94
0.40
1.6
1.7
%
1.5
1.5
0.18
218
2405
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.0
—
1.1
—
0
10
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
18
0.00
0.40
0.0
1.4
—
366.1
—
0
18
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
735
7135
1.04
0.39
2.8
2.7
ug/l
0.8
0.7
0.52
509
4912
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
19
151
1.26
0.38
2.5
2.4
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
34
289
1.18
0.38
2.3
2.3
ml
826.3
624.5
1.02
18
188
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
82
904
0.90
0.37
1.5
1.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
10
72
1.39
0.36
1.1
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
64
574
1.12
0.35
2.0
1.8
iu/l
11.3
4.7
1.19
19
183
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
80
879
0.91
0.35
2.6
2.3
ug/min
191.7
108.7
0.47
51
517
(3028300) Cannabinoids [Presence] in Urine
41
469
0.87
0.35
1.1
1.9
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
27
318
0.85
0.33
1.3
1.3
mmol/l
7.8
7.7
0.07
21
221
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
15
188
0.80
0.33
1.1
1.3
u/ml
0.4
1.3
—
6
94
(3020491) Glucose [Moles/volume] in Blood
19
231
0.82
0.32
1.3
2.4
mmol/l
7.9
6.6
0.87
14
145
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
6
47
1.28
0.32
1.0
1.2
—
75.7
—
0
12
(3000285) Sodium [Moles/volume] in Blood
6
47
1.28
0.32
1.2
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
11
143
0.77
0.32
1.0
1.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
13
165
0.79
0.32
1.4
1.5
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
32
276
1.16
0.31
1.2
1.7
u/ml
39.2
26.2
—
5
73
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
45
399
1.13
0.31
1.6
1.5
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
10
75
1.33
0.30
1.0
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
15
185
0.81
0.29
1.5
1.6
—
—
—
0
0
(4094501)
77
837
0.92
0.29
1.2
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
15
183
0.82
0.27
10.9
11.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
379
3914
0.96
0.26
4.3
5.0
%
31.3
32.8
1.79
262
2575
(3042733) HLA Ab [Presence] in Serum
10
77
1.30
0.26
4.7
5.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
9
72
1.25
0.25
1.0
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
16
192
0.83
0.25
2.1
1.5
g/l
0.9
0.9
0.08
16
192
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
9
73
1.23
0.25
1.1
1.3
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
12
96
1.25
0.24
1.1
1.1
u/ml
4.4
1.6
—
5
32
(3011288) Drugs identified in Urine by Screen method
34
303
1.12
0.23
1.1
2.6
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
5
38
1.32
0.23
1.8
2.5
u/field
0.4
0.4
—
5
38
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1006
10214
0.98
0.22
4.2
3.8
%
21.4
24.1
6.78
511
5002
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
41
1.22
0.22
1.0
1.1
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
11
0.00
0.21
0.0
1.2
—
8.4
—
0
11
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
8
103
0.78
0.21
1.9
2.0
nmol/l
2.0
7.1
—
8
85
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
18
209
0.86
0.21
1.0
1.2
mmol/l
14.1
12.0
—
6
62
(3023430) Cat dander IgE Ab [Units/volume] in Serum
18
209
0.86
0.21
1.0
1.1
u/ml
2.3
4.2
—
5
87
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
5
43
1.16
0.21
1.0
1.3
nmol/l
11.0
207900.4
—
5
38
(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.1
—
34.3
—
0
5
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
6
51
1.18
0.19
2.2
1.8
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
19
217
0.87
0.18
1.7
1.4
pmol/l
82.6
219.2
—
10
61
(1001926) Buprenorphine [Presence] in Urine by Screen method
33
362
0.91
0.17
1.2
1.9
—
—
—
0
0
(4133840)
5
66
0.76
0.17
1.2
1.1
—
—
—
0
0
(4198724)
5
67
0.75
0.17
1.0
1.8
—
—
—
0
0
(3003338) MCHC [Mass/volume]
2312
23248
0.98
0.16
46.1
18.0
g/l
331.2
332.5
9.39
2292
23050
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
8
69
1.16
0.16
1.6
1.7
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
8
71
1.13
0.16
7.3
7.8
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
42
389
1.08
0.16
1.0
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
281
2741
1.03
0.15
1.4
1.4
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
35
322
1.09
0.15
3.6
3.1
mg/l
23.5
36.8
0.55
27
245
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
9
79
1.14
0.15
2.2
1.4
pmol/l
14.8
16.9
—
9
64
(3000475) Leukocytes [#/volume] in Synovial fluid
76
800
0.95
0.15
1.9
1.5
e6/l
17078.7
12913.2
0.27
61
586
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
10
85
1.18
0.12
2.3
2.1
ug/l
1.3
1.3
—
10
76
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
28
303
0.92
0.12
1.3
1.3
nmol/l
1.3
1.5
0.43
23
270
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
16
143
1.12
0.11
1.6
1.5
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
22
240
0.92
0.11
1.3
1.3
promille
1.4
1.3
0.07
17
184
(3019150) Specific gravity of Urine by Refractometry
642
6487
0.99
0.10
4.8
4.1
kg/l
1.0
1.0
0.34
105
975
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
34
361
0.94
0.09
1.2
1.3
pmol/l
254.9
280.8
0.32
27
274
(3015183) Erythrocyte sedimentation rate
11
97
1.13
0.09
1.1
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
75
725
1.04
0.08
1.0
1.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
41
391
1.05
0.08
1.5
1.5
%
62.3
62.1
0.01
26
260
(44813793)
15
164
0.91
0.08
1.1
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
6
75
0.80
0.07
1.2
1.1
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
13
143
0.91
0.07
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
13
143
0.91
0.07
1.4
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
54
560
0.96
0.07
1.2
1.8
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
11
122
0.90
0.07
1.5
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
35
334
1.05
0.06
1.3
1.3
nmol/l
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
13
142
0.92
0.06
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
13
142
0.92
0.06
1.4
1.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
9
101
0.89
0.06
2.1
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
11
120
0.92
0.05
1.3
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
11
119
0.92
0.04
1.3
1.4
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
10
92
1.09
0.03
6.4
7.7
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
58
569
1.02
0.02
1.5
1.4
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
39
380
1.03
0.02
1.3
1.3
mu/l
48.8
63.6
0.34
33
337
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
37
379
0.98
0.02
1.3
1.3
nmol/l
0.7
0.6
0.13
37
365
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
11
117
0.94
0.01
1.2
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
15
155
0.97
0.00
1.5
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
21
205
1.02
0.00
1.4
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
76
762
1.00
0.00
1.5
1.7
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
12
119
1.01
0.00
1.2
1.9
ug/l
266.4
84.3
0.31
12
109
(3006653) Thiamine [Moles/volume] in Blood
14
141
0.99
0.00
1.4
1.2
nmol/l
115.1
143.2
3.06
14
141
(3032773) Endomysium IgG Ab [Titer] in Serum
21
211
1.00
0.00
1.0
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
14
136
1.03
0.00
1.0
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
34
344
0.99
0.00
1.4
1.3
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
31.8
—
0
6
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
6
0.00
0.00
0.0
3.8
—
20.7
—
0
6
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
224.8
—
0
6
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
3.9
—
0
8
(3033882) Carnitine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
37.5
—
0
6
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
8
83
0.96
0.00
1.9
1.4
ug/l
11.9
9.0
—
8
83
(37021550) Renin [Units/volume] in Plasma --upright
6
60
1.00
0.00
1.3
1.3
mu/l
78.7
60.7
—
6
39
(3007463) Buprenorphine [Presence] in Urine
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
5
50
1.00
0.00
1.0
1.2
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
1352.0
—
0
5
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
9
0.00
0.00
0.0
7.8
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
6
66
0.91
0.00
1.0
1.5
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
8
84
0.95
0.00
7.2
7.7
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4038314)
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014171) Thiocyanate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
121.4
—
0
5
(3012989) Citrate [Moles/time] in 24 hour Urine
0
7
0.00
-0.00
0.0
1.4
—
2.3
—
0
7
(3017937) Magnesium [Moles/time] in 24 hour Urine
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

Index endpoint: CD2_NONFOLLICULAR_LYMPHOMA_EXALLC – Non-follicular lymphoma, hilmo, excluding all cancers

GWS hits: 5

This endpoint is excluded (different definition than used in FinnGen).